Document:

Exhibit
4.2

 

WARRANT
AGENT AGREEMENT

 

This
Warrant Agent Agreement (this “Warrant Agreement”), dated as of [  ], 2022 (the “Issuance Date”)
between CW Petroleum Corp, a company incorporated under the laws of the State of Wyoming (the “Company”), and Transfer
Online, Inc. (the “Warrant Agent”).

 

WHEREAS,
pursuant to the terms of that certain Underwriting Agreement (“Underwriting Agreement”), dated [   ], 2022,
by and among the Company and EF Hutton, division of Benchmark Investments, LLC, as representatives of the underwriters set forth therein,
the Company is engaged in the Company’s initial public offering (the “Offering”) of up to 3,000,000 Units, each
Unit consisting of one share (the “Shares”) of common stock, par value $0.0001 per share (the “Common Stock”)
of the Company and one Warrant to purchase one share of Common Stock (the “Public Warrants”) to purchase one share
of Common Stock (such shares of Common Stock underlying the Public Warrants, the “Public Warrant Shares”);

 

WHEREAS,
the Company has filed with the Securities and Exchange Commission (the “Commission”) a Registration Statement on Form
S-1 (File No. 333-265369) (as the same may be amended from time to time, the “Registration Statement”), for
the registration under the Securities Act of 1933, as amended (the “Securities Act”), of the Shares, the Public Warrants
and Public Warrant Shares, and such Registration Statement was declared effective on [__], 2022;

 

WHEREAS,
the Company desires the Warrant Agent to act on behalf of the Company, and the Warrant Agent is willing to so act, in accordance with
the terms set forth in this Warrant Agreement in connection with the issuance, registration, transfer, exchange and exercise of the Public
Warrants;

 

WHEREAS,
the Company desires to provide for the provisions of the Public Warrants, the terms upon which they shall be issued and exercised, and
the respective rights, limitation of rights, and immunities of the Company, the Warrant Agent, and the holders of the Public Warrants;
and

 

WHEREAS,
all acts and things have been done and performed which are necessary to make the Public Warrants the valid, binding and legal obligations
of the Company, and to authorize the execution and delivery of this Warrant Agreement.

 

NOW,
THEREFORE, in consideration of the mutual agreements herein contained, the parties hereto agree as follows:

 

1.
Appointment of Warrant Agent. The Company hereby appoints the Warrant Agent to act as agent for the Company with respect to the Public
Warrants, and the Warrant Agent hereby accepts such appointment and agrees to perform the same in accordance with the express terms and
conditions set forth in this Warrant Agreement (and no implied terms or conditions).

 

2.
Warrants.

 

2.1.
Form of Warrants.

 

(a)
The Public Warrants, together with the form of election to purchase the Common Stock (the “Exercise Notice”) and the
form of assignment to be printed on the reverse thereof shall be substantially in the form of Exhibit B hereto. The Public Warrants
shall be registered securities and shall be evidenced by a global certificate (“Global Certificate”) in the form of
Exhibit A to this Warrant Agreement, which shall be deposited on behalf of the Company with a custodian for The Depository Trust
Company (“DTC”) and registered in the name of Cede & Co., a nominee of DTC. If DTC subsequently ceases to make
its book- entry settlement system available for the Public Warrants, the Company may instruct the Warrant Agent regarding making other
arrangements for book-entry settlement.

 

    	1

     

    

 

(b)
In the event that any Public Warrants are not eligible for, or it is no longer necessary to have the Public Warrants available in, book-entry
form, then the Company may instruct the Warrant Agent to: (i) issue certificates (the “Warrant Certificates”); and
(ii) provide written instructions to DTC to deliver to the Warrant Agent for cancellation the Global Certificate; and (iii) the Company
shall instruct the Warrant Agent to deliver to DTC separate Warrant Certificates as requested through the DTC system.

 

2.2.
Issuance and Registration of Warrants.

 

2.2.1.
Warrant Register. The Warrant Agent shall maintain books (“Warrant Register”) for the registration of original
issuance and the registration of transfer of the Public Warrants.

 

2.2.2.
Issuance of Public Warrants. Upon the initial issuance of the Public Warrants, the Warrant Agent shall issue the Global Certificate
and deliver the Public Warrants in the DTC book-entry settlement system in accordance with written instructions delivered to the Warrant
Agent by the Company. Ownership of security entitlements in the Public Warrants shall be shown on, and the transfer of such ownership
shall be effected through, records maintained: (i) by DTC and (ii) by institutions that have accounts with DTC (each, a “Participant”).

 

2.2.3
[RESERVED.]

 

2.2.4.
Beneficial Owner; Holder. Prior to due presentment for registration of transfer of any Public Warrant, the Company and the Warrant
Agent may deem and treat the person in whose name that Public Warrant shall be registered on the Warrant Register (the “Holder”)
as the absolute owner of such Public Warrant for purposes of any exercise thereof, and for all other purposes, and neither the Company
nor the Warrant Agent shall be affected by any notice to the contrary. Notwithstanding the foregoing, nothing herein shall prevent the
Company, the Warrant Agent or any agent of the Company or the Warrant Agent from giving effect to any written certification, proxy or
other authorization furnished by DTC governing the exercise of the rights of a holder of a beneficial interest in any Public Warrant.
The rights of beneficial owners in a Public Warrant evidenced by the Global Certificate shall be exercised by the Holder or a Participant
through the DTC system, except to the extent set forth herein or in the Global Certificate.

 

2.2.5.
Execution. The Warrant Certificates shall be executed on behalf of the Company by any authorized officer of the Company (an “Authorized
Officer”), which need not be the same authorized signatory for all of the Warrant Certificates, either manually or by facsimile
signature. The Warrant Certificates shall be countersigned by an authorized signatory of the Warrant Agent, which need not be thesame
signatory for all of the Warrant Certificates, and no Warrant Certificate shall be valid for any purpose unless so countersigned. In
case any Authorized Officer of the Company that signed any of the Warrant Certificates ceases to be an Authorized Officer of the Company
before countersignature by the Warrant Agent and issuance and delivery by the Company, such Warrant Certificates, nevertheless, may be
countersigned by the Warrant Agent, issued and delivered with the same force and effect as though the person who signed such Warrant
Certificates had not ceased to be such officer of the Company; and any Warrant Certificate may be signed on behalf of the Company by
any person who, at the actual date of the execution of such Warrant Certificate, shall be an Authorized Officer of the Company authorized
to sign such Warrant Certificate, although at the date of the execution of this Warrant Agreement any such person was not such an Authorized
Officer.

 

    	2

     

    

 

2.2.6.
Registration of Transfer. At any time at or prior to the Expiration Date (as defined below), a transfer of any Public Warrants
may be registered and any Warrant Certificate or Warrant Certificates may be split up, combined or exchanged for another Warrant Certificate
or Warrant Certificates evidencing the same number of Public Warrants as the Warrant Certificate or Warrant Certificates surrendered.
Any Holder desiring to register the transfer of Public Warrants or to split up, combine or exchange any Warrant Certificate shall make
such request in writing delivered to the Warrant Agent, and shall surrender to the Warrant Agent the Warrant Certificate or Warrant Certificates
evidencing the Public Warrants the transfer of which is to be registered or that is or are to be split up, combined or exchanged and,
in the case of registration of transfer, shall provide a signature guarantee. Thereupon, the Warrant Agent shall countersign and deliver
to the person entitled thereto a Warrant Certificate or Warrant Certificates, as the case may be, as so requested. The Warrant Agent
may require reasonable and customary payment, by the Holder requesting a registration of transfer of Public Warrants or a split-up, combination
or exchange of a Warrant Certificate (but, for purposes of clarity, not upon the exercise of the Public Warrants and issuance of Public
Warrant Shares to the Holder), of a sum sufficient to cover any tax or governmental charge that may be imposed in connection with such
registration of transfer, split-up, combination or exchange, together with reimbursement to the Warrant Agent of all reasonable expenses
incidental thereto.

 

2.2.7.
Loss, Theft and Mutilation of Warrant Certificates. Upon receipt by the Company and the Warrant Agent of evidence reasonably satisfactory
to them of the loss, theft, destruction or mutilation of a Warrant Certificate, and, in case of loss, theft or destruction, of indemnity
or security in customary form and amount, and reimbursement to the Company and the Warrant Agent of all reasonable expenses incidental
thereto, and upon surrender to the Warrant Agent and cancellation of the Warrant Certificate if mutilated, the Warrant Agent shall, on
behalf of the Company, countersign and deliver a new Warrant Certificate of like tenor to the Holder in lieu of the Warrant Certificate
so lost, stolen, destroyed or mutilated. The Warrant Agent may charge the Holder an administrative fee for processing the replacement
of lost Warrant Certificates, which shall be charged only once in instances where a single surety bond obtained covers multiple certificates.
The Warrant Agent may receive compensation from the surety companies or surety agents for administrative services provided to them.

 

2.2.8.
Proxies. The Holder of a Public Warrant may grant proxies or otherwise authorize any person, including the Participants and beneficial
holders that may own interests through the Participants, to take any action that a Holder is entitled to take under this Agreement or
the Public Warrants; provided, however, that at all times that the Public Warrants are evidenced by a Global Certificate,
exercise of those Public Warrants shall be effected on their behalf by Participants through DTC in accordance the procedures administered
by DTC.

 

3.
[RESERVED.]

 

4.
Terms and Exercise of Warrants.

 

4.1.
Exercise Price. Each Public Warrant shall entitle the Holder, subject to the provisions of the applicable Warrant Certificate
and of this Warrant Agreement, to purchase from the Company the number of shares of Common Stock stated therein, at the price of $[__]
per whole share, subject to the subsequent adjustments provided in Section 5 hereof. The term “Exercise Price” as
used in this Warrant Agreement refers to the price per share at which shares of Common Stock may be purchased at the time a Public Warrant
is exercised.

 

4.2.
Duration of Public Warrants. Public Warrants may be exercised only during the period (“Exercise Period”)
commencing on [__], 2022 and terminating at 5:00 P.M., Eastern Standard Time (the “close of business”) on the fifth
(5th ) anniversary of the Issuance Date, [__], 2027 (“Expiration Date”). Each Public Warrant not exercised
on or before the Expiration Date shall become void, and all rights thereunder and all rights in respect thereof under this Warrant Agreement
shall cease at the close of business on the Expiration Date.

 

    	3

     

    

 

4.3.
Exercise of Warrants.

 

4.3.1.
Exercise and Payment. (a) Subject to the provisions of this Warrant Agreement, a Holder (or a Participant or a designee of a Participant
acting on behalf of a Holder) may exercise Public Warrants by delivering to the Warrant Agent, not later than 5:00 P.M., Eastern Standard
Time, on any business day during the Exercise Period an election to purchase the Public Warrant Shares underlying the Public Warrants
to be exercised (i) in the form included in Exhibit B to this Warrant Agreement or (ii) via an electronic warrant exercise through
the DTC system (each, an “Election to Purchase”). No later than one (1) Trading Day following delivery of an Election
to Purchase, the Holder (or a Participant acting on behalf of a Holder in accordance with DTC procedures) shall: (i) (A) surrender the
Warrant Certificate evidencing the Public Warrants to the Warrant Agent at its office designated for such purpose or (B) deliver the
Public Warrants to an account of the Warrant Agent at DTC designated for such purpose in writing by the Warrant Agent to DTC from time
to time, and (ii) unless the cashless exercise procedure specified in Section 3.3.7(b) or (c) below is permitted and specified in the
applicable Notice of Exercise, deliver to the Company the Exercise Price for each Public Warrant to be exercised, in lawful money of
the United States of America by certified or official bank check payable to the Company or bank wire transfer in immediately available
funds to:

 

Bank
Name: Bank of America

Account
Name: CW Petroleum Corp

Address:
5919 Hawthorne Garden Way

Katy,
TX 77494

ABA/Routing#:
111000025

Wire
Transfer# 026009593

Account#:
586030506467

 

Notwithstanding
any other provision in this Warrant Agreement, a Holder whose interest in a Global Warrant is a beneficial interest in a Global Warrant
held in book-entry form through DTC (or another established clearing corporation performing similar functions), shall effect exercises
by delivering to DTC (or such other clearing corporation, as applicable) the appropriate instruction form for exercise, complying with
the procedures to effect exercise that are required by DTC (or such other clearing corporation, as applicable). The Company acknowledges
that the bank accounts maintained by the Warrant Agent in connection with the services provided under this Agreement will be in its name
and that the Warrant Agent may receive investment earnings in connection with the investment at Warrant Agent’s risk and for its
benefit of funds held in those accounts from time to time. Neither the Company nor the Holders will receive interest on any deposits
or Exercise Price.

 

No
ink-original Election to Purchase shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of
any Election to Purchase form be required. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically
surrender the Public Warrants to the Warrant Agent until the Holder has purchased all of the Public Warrant Shares available thereunder
and the Public Warrant has been exercised in full, in which case, the Holder shall surrender such Public Warrant to the Warrant Agent
for cancellation within three (3) Trading Days of the date the final Election to Purchase is delivered to the Warrant Agent. Partial
exercises of a Public Warrant resulting in purchases of a portion of the total number of Public Warrant Shares available thereunder shall
have the effect of lowering the outstanding number of Public Warrant Shares purchasable hereunder in an amount equal to the applicable
number of Public Warrant Shares purchased. The Holder and the Warrant Agent shall maintain records showing the number of Warrant Shares
purchased and the date of such purchases. The Holder and any assignee, by acceptance of a Public Warrant, acknowledge and agree that,
by reason of the provisions of this paragraph, following the purchase of a portion of the Public Warrant Shares hereunder, the number
of Public Warrant Shares available for purchase hereunder at any given time may be less than the amount stated on the face thereof.

 

Any
person so designated by the Holder (or a Participant or designee of a Participant on behalf of a Holder) to receive Public Warrant Shares
shall be deemed to have become holder of record of such Public Warrant Shares as of the time that an appropriately completed and duly
signed Election to Purchase has been delivered to the Warrant Agent, provided that the Holder (or Participant on behalf of the Holder)
makes delivery of the deliverables referenced in the immediately preceding sentence by the date that is one (1) Trading Day after the
delivery of the Election to Purchase. If the Holder (or Participant on behalf of the Holder) fails to make delivery of such deliverables
on or prior to the Trading Day following delivery of the Election to Purchase, such Election to Purchase shall be void ab initio.

 

    	4

     

    

 

(b)
If any of (i) the Public Warrants, (ii) the Election to Purchase, or (iii) the Exercise Price therefor, is received by the Warrant Agent
on any date after 5:00 P.M., Eastern Standard Time, or on a date that is not a Trading Day, the Public Warrants with respect thereto
will be deemed to have been received and exercised on the Trading Day next succeeding such date. “Business day” means
a day other than a Saturday or Sunday on which commercial Banks in New York City are open for the general conduct of banking business.
The “Exercise Date” will be the date on which the materials in the foregoing sentence are received by the Warrant
Agent (if by 5:00 P.M., New York City time), or the following Trading Day (if after 5:00 P.M., New York City time), regardless of any
earlier date written on the materials. If the Public Warrants are received or deemed to be received after the Expiration Date, the exercise
thereof will be null and void and any funds delivered to the Company will be returned to the Holder or Participant, as the case may be,
as soon as practicable. In no event will interest accrue on any funds deposited with the Company in respect of an exercise or attempted
exercise of the Public Warrants.

 

(c)
The Warrant Agent shall deposit all funds received by it in payment of the Exercise Price for all Public Warrants in the account of the
Company maintained with the Warrant Agent for such purpose (or to such other account as directed by the Company in writing) and shall
advise the Company via telephone at the end of each day on which funds for the exercise of any Public Warrant are received of the amount
so deposited to its account. The Warrant Agent shall promptly confirm such telephonic advice to the Company in writing.

 

(d)
If less than all the Public Warrants evidenced by a surrendered Warrant Certificate are exercised, the Warrant Agent shall split up the
surrendered Warrant Certificate and return to the Holder a Warrant Certificate evidencing the Public Warrants that were not exercised.

 

4.3.2.
Issuance of Public Warrant Shares.

 

(a)
The Warrant Agent shall, no later than the Trading Day following the Exercise Date of any Public Warrant, advise the Company in respect
of (i) the number of Public Warrant Shares indicated on the Election to Purchase as issuable upon such exercise with respect to such
exercised Public Warrants, (ii) the instructions of the Holder or Participant, as the case may be, provided to the Warrant Agent with
respect to the delivery of the Public Warrant Shares and the number of Public Warrants that remain outstanding after such exercise, (iii)
the amount of funds for which the exercise of such Public Warrant is received, and (iv) such other information as the Company shall reasonably
request. The Company shall deliver any objection to any Election to Purchase within one (1) Business day of receipt of such notice.

 

(b)
The Warrant Agent shall cause, by no later than 5:00 P.M., Eastern Standard Time, on the third Trading Day following the delivery of
the Election to Purchase (provided the payment of the Exercise Price has been submitted as required by Section 4.3.1) (such date and
time, the “Delivery Time”), to electronically transmit the Public Warrant Shares issuable upon that exercise to DTC
by crediting the account of DTC or of the Participant, as the case may be, through its Deposit/Withdrawal at Custodian (DWAC) system.
The Company agrees to maintain a transfer agent that is a participant in the FAST program so long as this Public Warrant remains outstanding
and exercisable.

 

4.3.3.
Valid Issuance. All Public Warrant Shares issued by the Company upon the proper exercise of a Public Warrant in conformity with
this Warrant Agreement shall be validly issued, fully paid and non-assessable.

 

4.3.4.
No Fractional Exercise. No fractional Public Warrant Shares will be issued upon the exercise of the Public Warrant. If, by reason
of any adjustment made pursuant to Section 5, a Holder would be entitled, upon the exercise of such Public Warrant, to receive a fractional
interest in a share, the Company shall, upon such exercise, round up or down, as applicable, to the nearest whole number the number of
Public Warrant Shares to be issued to such Holder.

 

    	5

     

    

 

4.3.5.
No Transfer Taxes. Issuance of Public Warrant Shares shall be made without charge to the Holder for any issue or transfer tax
or other incidental expense in respect of the issuance of such Public Warrant Shares, all of which taxes and expenses shall be paid by
the Company, and such Public Warrant Shares shall be issued in the name of the Holder or in such name or names as may be directed by
the Holdert; provided, however, that in the event Public Warrant Shares are to be issued in a name other than the name
of the Holder, the Public Warrant when surrendered for exercise shall be accompanied by an assignment form duly executed by the Holder
and the Company may require, as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental
thereto. The Company shall not be required to issue or deliver any certificate for shares of Common Stock upon the exercise of any Public
Warrants until any such tax or governmental charge shall have been paid (any such tax or governmental charge being payable by the Holder
of such Warrant Certificate at the time of surrender) or until it has been established to the Company’s reasonable satisfaction
that no such tax or governmental charge is due. Additionally, the Company may require payment from the Holder of a sum sufficient to
cover any tax or governmental charge that may be imposed in connection with any split up, combination or exchange of Public Warrants.
The Company shall pay all Transfer Agent fees required for same-day processing of any Election to Purchase and all fees to the Depository
Trust Company (or another established clearing corporation performing similar functions) required for same-day electronic delivery of
the Public Warrant Shares.

 

4.3.6.
Date of Issuance. The Company will treat an exercising Holder as a beneficial owner of the Public Warrant Shares as of the Exercise
Date, except that, if the Exercise Date is a date when the stock transfer books of the Company are closed, such person shall be deemed
to have become the holder of such shares at the open of business on the next succeeding date on which the stock transfer books are open.

 

4.3.7.
Restrictive Legend Events. (a) The Company shall use it reasonable best efforts to maintain the effectiveness of the Registration
Statement and the current status of the prospectus included therein or to file and maintain the effectiveness of another registration
statement or to file a registration statement and another current prospectus covering the Public Warrants and the Public Warrant Shares
at any time that t Public Warrants are exercisable. The Company shall provide to the Warrant Agent and each Holder prompt written notice
of any time that the Company is unable to deliver the Public Warrant Shares via DTC transfer or otherwise without restrictive legend
because (i) the Commission has issued a stop order with respect to the Registration Statement, (ii) the Commission otherwise has suspended
or withdrawn the effectiveness of the Registration Statement, either temporarily or permanently, (iii) the Company has suspended or withdrawn
the effectiveness of the Registration Statement, either temporarily or permanently, (iv) the prospectus contained in the Registration
Statement is not available for the issuance of the Public Warrant Shares to the Holder , or (v) otherwise (each a “Restrictive
Legend Event”). To the extent that the Public Warrants cannot be exercised as a result of a Restrictive Legend Event or a Restrictive
Legend Event occurs after a Holder has exercised Public Warrants in accordance with the terms of the Public Warrants but prior to the
delivery of the Public Warrant Shares, the Company shall, at the election of the Holder, which shall be given within five (5) days of
receipt of such notice of the Restrictive Legend Event, either (A) rescind the previously submitted Election to Purchase and the Company
shall return all consideration paid by registered holder for such shares upon such rescission, or (B) treat the attempted exercise as
a cashless exercise as described in paragraph (b) below and refund the cash portion of the exercise price to the Holder. Notwithstanding
anything herein to the contrary, the Company shall not be required to make any cash payments or net cash settlement to the Holder in
lieu of delivery of the Public Warrant Shares.

 

    	6

     

    

 

(b)
If a Restrictive Legend Event has occurred, the Public Warrant shall only be exercisable on a cashless basis. Upon a “cashless
exercise”, the Holder shall be entitled to receive the number of Public Warrant Shares equal to the quotient obtained by dividing
(A-B) (X) by (A), where:

 

	 	(A)
                                            =
	the
    last VWAP immediately preceding the date of exercise giving rise to the applicable “cashless exercise”, as set forth
    in the applicable Election to Purchase (to clarify, the “last VWAP” will be the last VWAP as calculated over an entire
    Trading Day such that, in the event that this Warrant is exercised at a time that the Trading Market is open, the prior Trading Day’s
    VWAP shall be used in this calculation);
	 	 	 
	 	(B) =	the Exercise Price of the
    Public Warrant, as adjusted as set forth herein; and
	 	 	 
	 	(X)
                                    =
	the number of Public Warrant
    Shares that would be issuable upon exercise of the Public Warrant in accordance with the terms of the Public Warrant if such exercise
    were by means of a cash exercise rather than a cashless exercise.

 

If
the Public Warrant Shares are issued in such a cashless exercise, the Company acknowledges and agrees that, in accordance with Section
3(a)(9) of the Securities Act, the Public Warrant Shares shall take on the registered characteristics of the Public Warrants being exercised
and the Company agrees not to take any position contrary thereto. Upon receipt of an Election to Purchase for a cashless exercise, the
Warrant Agent will promptly deliver a copy of the Election to Purchase to the Company to confirm the number of Public Warrant Shares
issuable in connection with the cashless exercise. The Company shall calculate and transmit to the Warrant Agent in a written notice,
and the Warrant Agent shall have no duty, responsibility or obligation under this section to calculate, the number of Public Warrant
Shares issuable in connection with any cashless exercise. The Warrant Agent shall be entitled to rely conclusively on any such written
notice provided by the Company, and the Warrant Agent shall not be liable for any action taken, suffered or omitted to be taken by it
in accordance with such written instructions or pursuant to this Warrant Agreement.

 

4.3.8.
Disputes. In the case of a dispute as to the determination of the Exercise Price or the arithmetic calculation of the number of
Public Warrant Shares issuable in connection with any exercise, the Company shall promptly deliver to the Holder the number of Public
Warrant Shares that are not disputed.

 

4.3.9
[Reserved.]

 

    	7

     

    

 

4.3.10
Beneficial Ownership Limitation. The Company shall not affect any exercise of a Public Warrant, and a Holder shall not have the
right to exercise any portion of a Public Warrant, pursuant to this Section 4 or otherwise, to the extent that after giving effect to
such issuance after exercise as set forth on the applicable Election to Purchase, the Holder (together with the Holder’s Affiliates,
and any other persons acting as a group together with the Holder or any of the Holder’s Affiliates (such persons, “Attribution
Parties”)), would beneficially own in excess of the Beneficial Ownership Limitation (as defined below). For purposes of the
foregoing sentence, the number of shares of Common Stock beneficially owned by the Holder and its Affiliates and Attribution Parties
shall include the number of shares of Common Stock issuable upon exercise of such Public Warrant with respect to which such determination
is being made, but shall exclude the number of shares of Common Stock which would be issuable upon (i) exercise of the remaining, non-exercised
portion of such Public Warrant beneficially owned by the Holder or any of its Affiliates or Attribution Parties and (ii) exercise or
conversion of the unexercised or non-converted portion of any other securities of the Company (including, without limitation, any other
securities of the Company or its subsidiaries which would entitle the holder thereof to acquire at any time Common Stock, including,
without limitation, any debt, preferred stock, right, option, warrant, or other instruments that is at any time convertible into or exercisable
or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock (“Common Stock Equivalents”)
subject to a limitation on conversion or exercise analogous to the limitation contained herein beneficially owned by the Holder or any
of its Affiliates or Attribution Parties. Except as set forth in the preceding sentence, for purposes of this Section 4.3.10, beneficial
ownership shall be calculated in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder,
it being acknowledged by the Holder that the Company is not representing to the Holder that such calculation is in compliance with Section
13(d) of the Exchange Act and the Holder is solely responsible for any schedules required to be filed in accordance therewith. To the
extent that the limitation contained in this Section 4.3.10 applies, the determination of whether a Public Warrant is exercisable (in
relation to other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of a Public
Warrant is exercisable shall be in the sole discretion of the Holder, and the submission of a Notice of Exercise shall be deemed to be
the Holder’s determination of whether a Public Warrant is exercisable (in relation to other securities owned by the Holder together
with any Affiliates and Attribution Parties) and of which portion of a Public Warrant is exercisable, in each case subject to the Beneficial
Ownership Limitation, and the Company shall have no obligation to verify or confirm the accuracy of such determination. In addition,
a determination as to any group status as contemplated above shall be determined in accordance with Section 13(d) of the Exchange Act
and the rules and regulations promulgated thereunder. For purposes of this Section 4.3.10, in determining the number of outstanding shares
of Common Stock, a Holder may rely on the number of outstanding shares of Common Stock as reflected in (A) the Company’s most recent
periodic or annual report filed with the Commission, as the case may be, (B) a more recent public announcement by the Company, or (C)
a more recent written notice by the Company or the Transfer Agent setting forth the number of shares of Common Stock outstanding. Upon
the written or oral request of a Holder, the Company shall within one Trading Day confirm orally and in writing to the Holder the number
of shares of Common Stock then outstanding. In any case, the number of outstanding shares of Common Stock shall be determined after giving
effect to the conversion or exercise of securities of the Company, including such Public Warrant, by the Holder or its Affiliates or
Attribution Parties since the date as of which such number of outstanding shares of Common Stock was reported. The “Beneficial
Ownership Limitation” shall be 4.99% (or, upon election by a Holder prior to the issuance of any Public Warrants, 9.99%) of
the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock issuable
upon exercise of a Public Warrant. The Holder, upon notice to the Company, may increase or decrease the Beneficial Ownership Limitation
provisions of this Section 4.3.10, provided that the Beneficial Ownership Limitation in no event exceeds 9.99% of the number of shares
of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock upon exercise of this Public
Warrant held by the Holder and the provisions of this Section 4.3.10 shall continue to apply. Any increase in the Beneficial Ownership
Limitation will not be effective until the 61st day after such notice is delivered to the Company. The provisions of this
paragraph shall be construed and implemented in a manner otherwise than in strict conformity with the terms of this Section 4.3.10 to
correct this paragraph (or any portion hereof) which may be defective or inconsistent with the intended Beneficial Ownership Limitation
herein contained or to make changes or supplements necessary or desirable to properly give effect to such limitation. The limitations
contained in this paragraph shall apply to a successor holder of this Public Warrant.

 

    	8

     

    

 

5.
Adjustments.

 

5.1.
Stock Dividends and Splits. If the Company, at any time while the Public Warrants are outstanding: (i) pays a stock dividend or
otherwise makes a distribution or distributions on Common Stock or any other equity or equity equivalent securities payable in shares
of Common Stock (which, for avoidance of doubt, shall not include any Public Warrant Shares issued by the Company upon exercise of the
Public Warrants), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way
of reverse stock split) outstanding shares of Common Stock into a smaller number of shares, or (iv) issues by reclassification of Common
Stock any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which the
numerator shall be the number of shares of Common Stock and such other capital stock of the Company (excluding treasury shares, if any)
outstanding immediately before such event and of which the denominator shall be the number of shares of Common Stock and such other capital
stock of the Company (excluding treasury shares, if any) outstanding immediately after such event, and the number of shares issuable
upon exercise of the Public Warrants shall be proportionately adjusted such that the aggregate Exercise Price of the Public Warrants
shall remain unchanged. Any adjustment made pursuant to this Section 5.1 shall become effective immediately after the record date for
the determination of shareholders entitled to receive such dividend or distribution and shall become effective immediately after the
effective date in the case of a subdivision, combination, or re-classification.

 

5.2.
Subsequent Equity Sales. If the Company or any subsidiary thereof, as applicable, at any time while the Public Warrants are outstanding,
shall sell, enter into an agreement to sell, or grant any option to purchase, or sell, enter into an agreement to sell, or grant any
right to reprice, or otherwise dispose of or issue (or announce any offer, sale, grant or any option to purchase or other disposition)
any Common Stock or Common Stock Equivalents, at an effective price per share less than the Exercise Price then in effect (such lower
price, the “Base Share Price” and such issuances collectively, a “Dilutive Issuance”) (it being understood
and agreed that if the holder of the Common Stock or Common Stock Equivalents so issued shall at any time, whether by operation of purchase
price adjustments, reset provisions, floating conversion, exercise or exchange prices or otherwise, or due to warrants, options or rights
per share which are issued in connection with such issuance, be entitled to receive shares of Common Stock at an effective price per
share that is less than the Exercise Price, such issuance shall be deemed to have occurred for less than the Exercise Price on such date
of the Dilutive Issuance at such effective price), then simultaneously with the consummation (or, if earlier, the announcement) of each
Dilutive Issuance the Exercise Price shall be reduced and only reduced to equal the Base Share Price provided that the Base Share Price
shall not be less than $[__] (subject to adjustment for reverse and forward stock splits, recapitalizations and similar transactions
following the Issuance Date). Notwithstanding the foregoing, no adjustments shall be made, paid, or issued under this Section 5.2 in
respect of an Exempt Issuance. The Company shall notify the Holder, in writing, no later than the Trading Day following the issuance
or deemed issuance of any shares of Common Stock or Common Stock Equivalents subject to this Section 5.2, indicating therein the applicable
issuance price, or applicable reset price, exchange price, conversion price and other pricing terms (such notice, the “Dilutive
Issuance Notice”). For purposes of clarification, whether or not the Company provides a Dilutive Issuance Notice pursuant to
this Section 5.2, upon the occurrence of any Dilutive Issuance, the Holder is entitled to receive a number of Public Warrant Shares based
upon the Base Share Price regardless of whether the Holder accurately refers to the Base Share Price in the Notice of Exercise. If the
Company enters into a Variable Rate Transaction, the Company shall be deemed to have issued shares of Common Stock or Common Stock Equivalents
at the lowest possible price, conversion price, or exercise price at which such securities may be issued, converted or exercised.

 

    	9

     

    

 

5.3.
Subsequent Rights Offerings. In addition to any adjustments pursuant to Section 5.1 above, if at any time the Company grants,
issues or sells any Common Stock Equivalents or rights to purchase stock, warrants, securities or other property pro rata to the record
holders of any class of Common Stock (the “Purchase Rights”), then the Holder will be entitled to acquire, upon the
terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had held the
number of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise hereof,
including without limitation, the Beneficial Ownership Limitation) immediately before the date on which a record is taken for the grant,
issuance or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record holders of Common Stock are
to be determined for the grant, issue or sale of such Purchase Rights (provided, however, that, to the extent that the Holder’s
right to participate in any such Purchase Right would result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder
shall not be entitled to participate in such Purchase Right to such extent (or beneficial ownership of such shares of Common Stock as
a result of such Purchase Right to such extent) and such Purchase Right to such extent shall be held in abeyance for the Holder until
such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation).

 

5.4.
Pro Rata Distributions. During such time as the Public Warrants are outstanding, if the Company shall declare or make any dividend
or other distribution of its assets (or rights to acquire its assets) to holders of Common Stock, by way of return of capital or otherwise
(including, without limitation, any distribution of cash, stock or other securities, property or options by way of a dividend, spin off,
reclassification, corporate rearrangement, scheme of arrangement or other similar transaction) (a “Distribution”),
at any time after the issuance of the Pubic Warrants, then, in each such case, the Holder shall be entitled to participate in such Distribution
to the same extent that the Holder would have participated therein if the Holder had held the number of Public Warrant Shares acquirable
upon complete exercise of the Public Warrants (without regard to any limitations on exercise hereof, including without limitation, the
Beneficial Ownership Limitation) immediately before the date of which a record is taken for such Distribution, or, if no such record
is taken, the date as of which the record holders of Common Stock are to be determined for the participation in such Distribution (provided,
however, that, to the extent that the Holder’s right to participate in any such Distribution would result in the Holder exceeding
the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Distribution to such extent (or in
the beneficial ownership of any shares of Common Stock as a result of such Distribution to such extent) and the portion of such Distribution
shall be held in abeyance for the benefit of the Holder until such time, if ever, as its right thereto would not result in the Holder
exceeding the Beneficial Ownership Limitation). To the extent that this Warrant has not been partially or completely exercised at the
time of such Distribution, such portion of the Distribution shall be held in abeyance for the benefit of the Holder until the Holder
has exercised the Public Warrant.

 

    	10

     

    

 

5.5.
Fundamental Transaction. If, at any time while the Public Warrants are outstanding,(i) the Company, directly or indirectly, in
one or more related transactions effects any merger or consolidation of the Company with or into another person, (ii) the Company, directly
or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially all of
its assets in one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange offer
(whether by the Company or another person) is completed pursuant to which holders of Common Stock are permitted to sell, tender or exchange
their shares for other securities, cash or property and has been accepted by the holders of 50% or more of the outstanding shares of
Common Stock, (iv) the Company, directly or indirectly, in one or more related transactions effects any reclassification, reorganization
or recapitalization of the Common Stock or any compulsory share exchange pursuant to which the Common Stock is effectively converted
into or exchanged for other securities, cash or property, or (v) the Company, directly or indirectly, in one or more related transactions
consummates a stock or share purchase agreement or other business combination (including, without limitation, a reorganization, recapitalization,
spin-off, merger or scheme of arrangement) with another person or group of persons whereby such other person or group acquires more than
50% of the outstanding shares of Common Stock (not including any shares of Common Stock held by the other person or other persons making
or party to, or associated or affiliated with the other persons making or party to, such stock or share purchase agreement or other business
combination) (each a “Fundamental Transaction”), then, upon any subsequent exercise of the Public Warrants, the Holder
shall have the right to receive, for each Public Warrant Share that would have been issuable upon such exercise immediately prior to
the occurrence of such Fundamental Transaction, at the option of the Holder (without regard to any limitation in Section 2(e) on the
exercise of the Public Warrants), the number of shares of capital stock of the successor or acquiring corporation or of the Company,
if it is the surviving corporation, and any additional consideration (the “Alternate Consideration”) receivable as
a result of such Fundamental Transaction by a holder of the number of shares of Common Stock for which the Public Warrants are exercisable
immediately prior to such Fundamental Transaction. For purposes of any such exercise, the determination of the Exercise Price shall be
appropriately adjusted to apply to such Alternate Consideration based on the amount of Alternate Consideration issuable in respect of
one Public Warrant Share in such Fundamental Transaction, and the Company shall apportion the Exercise Price among the Alternate Consideration
in a reasonable manner reflecting the relative value of any different components of the Alternate Consideration. If holders of Common
Stock are given any choice as to the securities, cash, or property to be received in a Fundamental Transaction, then the Holder shall
be given the same choice as to the Alternate Consideration it receives upon any exercise of the Public Warrants following such Fundamental
Transaction. Notwithstanding anything to the contrary, in the event of a Fundamental Transaction, the Company or any Successor Entity
(as defined below) shall, at the Holder’s option, exercisable at any time concurrently with, or within 30 days after, the consummation
of the Fundamental Transaction (or, if later, the date of the public announcement of the applicable Fundamental Transaction), purchase
the Public Warrant from the Holder by paying to the Holder an amount of cash equal to the Black Scholes Value (as defined below) of the
remaining unexercised portion of the Public Warrant on the date of the consummation of such Fundamental Transaction; provided, however,
that, if the Fundamental Transaction is not within the Company’s control, including not approved by the Company’s Board of
Directors, Holder shall only be entitled to receive from the Company or any Successor Entity the same type or form of consideration (and
in the same proportion), at the Black Scholes Value of the unexercised portion of the Public Warrant, that is being offered and paid
to the holders of Common Stock of the Company in connection with the Fundamental Transaction, whether that consideration be in the form
of cash, stock or any combination thereof, or whether the holders of Common Stock are given the choice to receive from among alternative
forms of consideration in connection with the Fundamental Transaction; provided, further, that if holders of Common Stock of the Company
are not offered or paid any consideration in such Fundamental Transaction, such holders of Common Stock will be deemed to have received
Common Stock of the Successor Entity (which Entity may be the Company following such Fundamental Transaction) in such Fundamental Transaction.
“Black Scholes Value” means the value of the Public Warrant based on the Black-Scholes Option Pricing Model obtained from
the “OV” function on Bloomberg determined as of the day of consummation of the applicable Fundamental Transaction
for pricing purposes and reflecting (A) a risk-free interest rate corresponding to the U.S. Treasury rate for a period equal to the time
between the date of the public announcement of the applicable Fundamental Transaction and the Termination Date, (B) an expected volatility
equal to the greater of 100% and the 100 day volatility obtained from the HVT function on Bloomberg (determined utilizing a 365 day annualization
factor) as of the Trading Day immediately following the public announcement of the applicable Fundamental Transaction, (C) the underlying
price per share used in such calculation shall be the greater of (i) the sum of the price per share being offered in cash, if any, plus
the value of any non-cash consideration, if any, being offered in such Fundamental Transaction and (ii) the highest VWAP during the period
beginning on the Trading Day immediately preceding the announcement of the applicable Fundamental Transaction (or the consummation of
the applicable Fundamental Transaction, if earlier) and ending on the Trading Day of the Holder’s request pursuant to this Sections
5.4 and 5.5 a remaining option time equal to the time between the date of the public announcement of the applicable Fundamental Transaction
and the Termination Date and (E) a zero cost of borrow. The payment of the Black Scholes Value will be made by wire transfer of immediately
available funds (or such other consideration) within the later of (i) five (5) Business Days of the Holder’s election and (ii)
the date of consummation of the Fundamental Transaction. The Company shall cause any successor entity in a Fundamental Transaction in
which the Company is not the survivor (the “Successor Entity”) to assume in writing all of the obligations of the
Company under the Public Warrant in accordance with the provisions of this Section 5.5 pursuant to written agreements in form and substance
reasonably satisfactory to the Holder and approved by the Holder (without unreasonable delay) prior to such Fundamental Transaction and
shall, at the option of the Holder, deliver to the Holder in exchange for the Public Warrant a security of the Successor Entity evidenced
by a written instrument substantially similar in form and substance to the Public Warrant which is exercisable for a corresponding number
of shares of capital stock of such Successor Entity (or its parent entity) equivalent to the Public Warrant Shares acquirable and receivable
upon exercise of the Public Warrant (without regard to any limitations on the exercise of the Public Warrant) prior to such Fundamental
Transaction, and with an exercise price which applies the exercise price hereunder to such shares of capital stock (but taking into account
the relative value of the Public Warrant Shares pursuant to such Fundamental Transaction and the value of such shares of capital stock,
such number of shares of capital stock and such exercise price being for the purpose of protecting the economic value of the Public Warrant
immediately prior to the consummation of such Fundamental Transaction), and which is reasonably satisfactory in form and substance to
the Holder. Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall succeed to, and be substituted for (so
that from and after the date of such Fundamental Transaction, the provisions of the Public Warrant referring to the “Company”
shall refer instead to the Successor Entity), and may exercise every right and power of the Company and shall assume all of the obligations
of the Company under the Public Warrant with the same effect as if such Successor Entity had been named as the Company herein.

 

    	11

     

    

 

5.6.
Calculations. All calculations under this Section 5 shall be made to the nearest cent or the nearest 1/100th of a share, as the
case may be. For purposes of this Section 5, the number of shares of Common Stock deemed to be issued and outstanding as of a given date
shall be the sum of the number shares of Common Stock (excluding treasury shares, if any) issued and outstanding.

 

5.7.
Notice to Holder.

 

5.7.1.
Adjustment to Exercise Price. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 5, the Company
shall promptly deliver to the Holder by facsimile or email a notice setting forth the Exercise Price after such adjustment and any resulting
adjustment to the number of Public Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.

 

5.7.2.
Notice to Allow Exercise by Holder. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on
the Common Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C) the
Company shall authorize the granting to all holders of the Common Stock rights or warrants to subscribe for or purchase any shares of
capital stock of any class or of any rights, (D) the approval of any shareholders of the Company shall be required in connection with
any reclassification of the Common Stock, any consolidation or merger to which the Company (or any of its Subsidiaries) is a party, any
sale or transfer of all or substantially all of the assets of the Company, or any compulsory share exchange whereby the Common Stock
are converted into other securities, cash or property, or (E) the Company shall authorize the voluntary or involuntary dissolution, liquidation
or winding up of the affairs of the Company, then, in each case, the Company shall cause to be delivered by facsimile or email to the
Holder at its last facsimile number or email address as it shall appear upon the Warrant Register of the Company, at least 20 calendar
days prior to the applicable record or effective date hereinafter specified, a notice stating (x) the date on which a record is to be
taken for the purpose of such dividend, distribution, redemption, rights or warrants, or if a record is not to be taken, the date as
of which the holders of the Common Stock of record to be entitled to such dividend, distributions, redemption, rights or warrants are
to be determined or (y) the date on which such reclassification, consolidation, merger, sale, transfer or share exchange is expected
to become effective or close, and the date as of which it is expected that holders of the Common Stock of record shall be entitled to
exchange their shares of Common Stock for securities, cash or other property deliverable upon such reclassification, consolidation, merger,
sale, transfer or share exchange; provided that the failure to deliver such notice or any defect therein or in the delivery thereof shall
not affect the validity of the corporate action required to be specified in such notice. To the extent that any notice provided in the
Public Warrant constitutes, or contains, material, non-public information regarding the Company or any of the Subsidiaries, the Company
shall simultaneously file such notice with the Commission pursuant to a Current Report on Form 8-K. The Holder shall remain entitled
to exercise the Public Warrant during the period commencing on the date of such notice to the effective date of the event triggering
such notice except as may otherwise be expressly set forth herein.

 

5.8.
Voluntary Adjustment by Company. Subject to the rules and regulations of the Trading Market, the Company may at any time during
the term of the Public Warrants, subject to the prior written consent of the Holders, reduce the then current Exercise Price to any amount
and for any period of time deemed appropriate by the board of directors of the Company.

 

6.
Restrictive Legends; Fractional Warrants. In the event that a Warrant Certificate surrendered for transfer bears a restrictive
legend, the Warrant Agent shall not register that transfer until the Warrant Agent has received an opinion of counsel for the Company
stating that such transfer may be made and indicating whether the Public Warrants must also bear a restrictive legend upon that transfer.
The Warrant Agent shall not be required to effect any registration of transfer or exchange which will result in the transfer of or delivery
of a Warrant Certificate for a fraction of a Public Warrant.

 

    	12

     

    

 

7.
Other Provisions Relating to Rights of Holders of Warrants.

 

7.1.
No Rights as Stockholder. Except as otherwise specifically provided herein, a Holder, solely in its capacity as a holder of Public
Warrants, shall not be entitled to vote or receive dividends or be deemed the holder of share capital of the Company for any purpose,
nor shall anything contained in this Warrant Agreement be construed to confer upon a Holder, solely in its capacity as the registered
holder of Public Warrants, any of the rights of a stockholder of the Company or any right to vote, give or withhold consent to any corporate
action (whether any reorganization, issue of stock, reclassification of share capital, consolidation, merger, conveyance or otherwise),
receive notice of meetings, receive dividends or subscription rights or rights to participate in new issues of shares, or otherwise,
prior to the issuance to the Holder of the Public Warrant Shares which it is then entitled to receive upon the due exercise of Public
Warrants.

 

7.2.
Reservation of Common Stock. The Company shall at all times reserve and keep available a number of its authorized but unissued
shares of Common Stock that will be sufficient to permit the exercise in full of all outstanding Public Warrants issued pursuant to this
Warrant Agreement.

 

8.
Concerning the Warrant Agent and Other Matters.

 

8.1.
(a) Any instructions given to the Warrant Agent orally, as permitted by any provision of this Warrant Agreement, shall be confirmed in
writing by the Company as soon as practicable. The Warrant Agent shall not be liable or responsible and shall be fully authorized and
protected for acting, or failing to act, in accordance with any oral instructions which do not conform with the written confirmation
received in accordance with this Section 8.1. Whether or not any Public Warrants are exercised, for the Warrant Agent’s services
as agent for the Company hereunder, the Company shall pay to the Warrant Agent such fees as may be separately agreed between the Company
and Warrant Agent and the Warrant Agent’s reasonable out of pocket expenses in connection with this Warrant Agreement, including,
without limitation, the reasonable fees and expenses of the Warrant Agent’s counsel. While the Warrant Agent endeavors to maintain
out-of-pocket charges (both internal and external) at competitive rates, these charges may not reflect actual out-of-pocket costs, and
may include handling charges to cover internal processing and use of the Warrant Agent’s billing systems.

 

(b)
As agent for the Company hereunder the Warrant Agent: (a) shall have no duties or obligations other than those specifically set forth
herein or as may subsequently be agreed to in writing by the Warrant Agent and the Company;

 

(c)
shall be regarded as making no representations and having no responsibilities as to the validity, sufficiency, value, or genuineness
of the Public Warrants or any Public Warrant Shares; shall not be obligated to take any legal action hereunder;

 

(d)
may rely on and shall be fully authorized and protected in acting or failing to act upon any certificate, instrument, opinion, notice,
letter, telegram, telex, facsimile transmission or other document or security delivered to the Warrant Agent and believed by it to be
genuine and to have been signed by the proper party or parties;

 

(e)
shall not be liable or responsible for any recital or statement contained in the Registration Statement or any other documents relating
thereto;

 

(f)
shall not be liable or responsible for any failure on the part of the Company to comply with any of its covenants and obligations relating
to the Public Warrants, including without limitation obligations under applicable securities laws;

 

    	13

     

    

 

(g)
may rely on and shall be fully authorized and protected in acting or failing to act in good faith upon the written, telephonic or oral
instructions with respect to any matter relating to its duties as Warrant Agent covered by this Warrant Agreement (or supplementing or
qualifying any such actions) of officers of the Company, and is hereby authorized and directed to accept instructions with respect to
the performance of its duties hereunder from the Company or counsel to the Company, and may apply to the Company, for advice or instructions
in connection with the Warrant Agent’s duties hereunder, and the Warrant Agent shall not be liable for any delay in acting while
waiting for those instructions; any applications by the Warrant Agent for written instructions from the Company may, at the option of
the Warrant Agent, set forth in writing any action proposed to be taken or omitted by the Warrant Agent under this Warrant Agreement
and the date on or after which such action shall be taken or such omission shall be effective; the Warrant Agent shall not be liable
for any action taken by, or omission of, the Warrant Agent in accordance with a proposal included in such application on or after the
date specified in such application (which date shall not be less than five Business days after the date such application is sent to the
Company, unless the Company shall have consented in writing to any earlier date) unless prior to taking any such action, the Warrant
Agent shall have received written instructions in response to such application specifying the action to be taken or omitted;

 

(h)
may consult with counsel satisfactory to the Warrant Agent, including its in-house counsel, and the advice of such counsel shall be full
and complete authorization and protection in respect of any action taken, suffered, or omitted by it hereunder in good faith and in accordance
with the advice of such counsel;

 

(i)
may perform any of its duties hereunder either directly or by or through nominees, correspondents, designees, or subagents, and it shall
not be liable or responsible for any misconduct or negligence on the part of any nominee, correspondent, designee, or subagent appointed
with reasonable care by it in connection with this Warrant Agreement, provided reasonable care was exercised in the selection and continued
appointment thereof;

 

(j)
is not authorized, and shall have no obligation, to pay any brokers, dealers, or soliciting fees to any person; and

 

(k)
shall not be required hereunder to comply with the laws or regulations of any country other than the United States of America or any
political subdivision thereof.

 

8.2.
(a) In the absence of gross negligence or willful or willful misconduct on its part, the Warrant Agent shall not be liable for any action
taken, suffered, or omitted by it or for any error of judgment made by it in the performance of its duties under this Warrant Agreement.
Anything in this Warrant Agreement to the contrary notwithstanding, in no event shall Warrant Agent be liable for special, indirect,
incidental, consequential or punitive losses or damages of any kind whatsoever (including but not limited to lost profits), even if the
Warrant Agent has been advised of the possibility of such losses or damages and regardless of the form of action. Any liability of the
Warrant Agent will be limited in the aggregate to the amount of fees paid by the Company hereunder. The Warrant Agent shall not be liable
for any failures, delays or losses, arising directly or indirectly out of conditions beyond its reasonable control including, but not
limited to, acts of government, exchange or market ruling, suspension of trading, work stoppages or labor disputes, fires, civil disobedience,
riots, rebellions, storms, electrical or mechanical failure, computer hardware or software failure, communications facilities failures
including telephone failure, war, terrorism, insurrection, earthquakes, floods, acts of God or similar occurrences.

 

    	14

     

    

 

(b)
In the event any question or dispute arises with respect to the proper interpretation of the Public Warrants or the Warrant Agent’s
duties under this Warrant Agreement or the rights of the Company or of any Holder, the Warrant Agent shall not be required to act and
shall not be held liable or responsible for its refusal to act until the question or dispute has been judicially settled (and, if appropriate,
it may file a suit in interpleader or for a declaratory judgment for such purpose) by final judgment rendered by a court of competent
jurisdiction, binding on all persons interested in the matter which is no longer subject to review or appeal, or settled by a written
document in form and substance satisfactory to Warrant Agent and executed by the Company and each such Holder. In addition, the Warrant
Agent may require for such purpose, but shall not be obligated to require, the execution of such written settlement by all the Holders
and all other persons that may have an interest in the settlement.

 

8.3.
The Company covenants to indemnify the Warrant Agent and hold it harmless from and against any loss, liability, claim or expense (“Loss”)
arising out of or in connection with the Warrant Agent’s duties under this Warrant Agreement, including the reasonable costs and
expenses of defending itself against any Loss, unless such Loss shall have been determined by a court of competent jurisdiction to be
a result of the Warrant Agent’s gross negligence, bad faith or willful misconduct.

 

8.4.
Unless terminated earlier by the parties hereto, this Agreement shall terminate ninety (90) days after the earlier of the Expiration
Date and the date on which no Public Warrants remain outstanding (the “Termination Date”). On the Business day following
the Termination Date, the Agent shall deliver to the Company any entitlements, if any, held by the Warrant Agent under this Warrant Agreement.
The Warrant Agent’s right to be reimbursed for fees, charges and out-of-pocket expenses as provided in this Section 8 shall survive
the termination of this Warrant Agreement.

 

8.5.
If any provision of this Warrant Agreement shall be held illegal, invalid, or unenforceable by any court, this Warrant Agreement shall
be construed and enforced as if such provision had not been contained herein and shall be deemed an Agreement among the parties to it
to the full extent permitted by applicable law.

 

8.6.
The Company represents and warrants that: (a) it is duly incorporated and validly existing under the laws of its jurisdiction of incorporation;
(b) the offer and sale of the Public Warrants and the execution, delivery and performance of all transactions contemplated thereby (including
this Warrant Agreement) have been duly authorized by all necessary corporate action and will not result in a breach of or constitute
a default under the articles of association, bylaws or any similar document of the Company or any indenture, agreement or instrument
to which it is a party or is bound; (c) this Warrant Agreement has been duly executed and delivered by the Company and constitutes the
legal, valid, binding and enforceable obligation of the Company; (d) the Public Warrants will comply in all material respects with all
applicable requirements of law; and (e) to the best of its knowledge, there is no litigation pending or threatened as of the date hereof
in connection with the offering of the Public Warrants. In the event of inconsistency between this Warrant Agreement and the descriptions
in the Registration Statement, as they may from time to time be amended, the terms of this Warrant Agreement shall control.

 

8.7.
Set forth in Exhibit C hereto is a list of the names and specimen signatures of the persons authorized to act for the Company
under this Warrant Agreement (the “Authorized Representatives”). The Company shall, from time to time, certify to
you the names and signatures of any other persons authorized to act for the Company under this Warrant Agreement.

 

8.8.
Except as expressly set forth elsewhere in this Warrant Agreement, all notices, instructions and communications under this Agreement
shall be in writing, shall be effective upon receipt and shall be addressed, if to the Company, to its address set forth beneath its
signature to this Agreement, or, if to the Warrant Agent, to Transfer Online, Inc., 512 SE Salmon St., Portland, OR 97214, or to such
other address of which a party hereto has notified the other party.

 

    	15

     

    

 

8.9.
(a) This Warrant Agreement shall be governed by and construed in accordance with the laws of the State of New York. All actions and proceedings
relating to or arising from, directly or indirectly, this Warrant Agreement may be litigated in courts located within the Borough of
Manhattan in the City and State of New York. The Company hereby submits to the personal jurisdiction of such courts and consents that
any service of process may be made by certified or registered mail, return receipt requested, directed to the Company at its address
last specified for notices hereunder. Each of the parties hereto hereby waives the right to a trial by jury in any action or proceeding
arising out of or relating to this Warrant Agreement.

 

(b)
This Warrant Agreement shall inure to the benefit of and be binding upon the successors and assigns of the parties hereto. This Warrant
Agreement may not be assigned, or otherwise transferred, in whole or in part, by either party without the prior written consent of the
other party, which the other party will not unreasonably withhold, condition or delay; except that (i) consent is not required for an
assignment or delegation of duties by Warrant Agent to any affiliate of Warrant Agent and (ii) any reorganization, merger, consolidation,
sale of assets or other form of business combination by Warrant Agent or the Company shall not be deemed to constitute an assignment
of this Warrant Agreement.

 

(c)
No provision of this Warrant Agreement may be amended, modified or waived, except in a written document signed by both parties. The Company
and the Warrant Agent may amend or supplement this Warrant Agreement without the consent of any Holder for the purpose of curing any
ambiguity, or curing, correcting or supplementing any defective provision contained herein or adding or changing any other provisions
with respect to matters or questions arising under this Agreement as the parties may deem necessary or desirable and that the parties
determine, in good faith, shall not adversely affect the interest of the Holders. All other amendments and supplements shall require
the vote or written consent of Holders of at least 50.1% of the then outstanding Public Warrants and the holders of at least 50.1% of
the voting power of the Company’s voting securities, provided that adjustments may be made to the Public Warrant terms and rights
in accordance with Section 5 without such consent.

 

8.10.
Payment of Taxes. The Company will from time to time promptly pay all taxes and charges that may be imposed upon the Company or
the Warrant Agent in respect of the issuance or delivery of the Public Warrant Shares upon the exercise of the Public Warrants, but the
Company may require the Holders to pay any transfer taxes in respect of the Public Warrants or such shares. The Warrant Agent may refrain
from registering any transfer of Public Warrants or any delivery of any Public Warrant Shares unless or until the persons requesting
the registration or issuance shall have paid to the Warrant Agent for the account of the Company the amount of such tax or charge, if
any, or shall have established to the reasonable satisfaction of the Company and the Warrant Agent that such tax or charge, if any, has
been paid.

 

8.10.1.
Resignation of Warrant Agent; Appointment of Successor Warrant Agent. The Warrant Agent, or any successor to it hereafter
appointed, may resign its duties and be discharged from all further duties and liabilities hereunder after giving thirty (30) days’
notice in writing to the Company, or such shorter period of time agreed to by the Company. The Company may terminate the services of
the Warrant Agent, or any successor Warrant Agent, after giving thirty (30) days’ notice in writing to the Warrant Agent or successor
Warrant Agent, or such shorter period of time as agreed. If the office of the Warrant Agent becomes vacant by resignation, termination
or incapacity to act or otherwise, the Company shall appoint in writing a successor Warrant Agent in place of the Warrant Agent. If the
Company shall fail to make such appointment within a period of 30 days after it has been notified in writing of such resignation or incapacity
by the Warrant Agent, then the Holder may apply to any court of competent jurisdiction for the appointment of a successor Warrant Agent.
Pending appointment of a successor to such Warrant Agent, either by the Company or by such a court, the duties of the Warrant Agent shall
be carried out by the Company. Any successor Warrant Agent (but not including the initial Warrant Agent), whether appointed by the Company
or by such court, shall be a person organized and existing under the laws of any state of the United States of America, in good standing,
and authorized under such laws to exercise corporate trust powers and subject to supervision or examination by federal or state authority.
After appointment, any successor Warrant Agent shall be vested with all the authority, powers, rights, immunities, duties, and obligations
of its predecessor Warrant Agent with like effect as if originally named as Warrant Agent hereunder, without any further act or deed,
and except for executing and delivering documents as provided in the sentence that follows, the predecessor Warrant Agent shall have
no further duties, obligations, responsibilities or liabilities hereunder, but shall be entitled to all rights that survive the termination
of this Warrant Agreement and the resignation or removal of the Warrant Agent, including but not limited to its right to indemnity hereunder.
If for any reason it becomes necessary or appropriate or at the request of the Company, the predecessor Warrant Agent shall execute and
deliver, at the expense of the Company, an instrument transferring to such successor Warrant Agent all the authority, powers, and rights
of such predecessor Warrant Agent hereunder; and upon request of any successor Warrant Agent the Company shall make, execute, acknowledge,
and deliver any and all instruments in writing for more fully and effectually vesting in and confirming to such successor Warrant Agent
all such authority, powers, rights, immunities, duties, and obligations.

 

    	16

     

    

 

8.10.2.
Notice of Successor Warrant Agent. In the event a successor Warrant Agent shall be appointed, the Company shall give notice thereof
to the predecessor Warrant Agent and the transfer agent for the Common Stock not later than the effective date of any such appointment.

 

8.10.3.
Merger or Consolidation of Warrant Agent. Any person into which the Warrant Agent may be merged or converted or with which it
may be consolidated or any person resulting from any merger, conversion or consolidation to which the Warrant Agent shall be a party
or any person succeeding to the shareowner services business of the Warrant Agent or any successor Warrant Agent shall be the successor
Warrant Agent under this Warrant Agreement, without any further act or deed. For purposes of this Warrant Agreement, “person”
shall mean any individual, firm, corporation, partnership, limited liability company, joint venture, association, trust or other entity,
and shall include any successor (by merger or otherwise) thereof or thereto.

 

9.
Miscellaneous Provisions.

 

9.1.
Persons Having Rights under this Warrant Agreement. Nothing in this Warrant Agreement expressed and nothing that may be implied
from any of the provisions hereof is intended, or shall be construed, to confer upon, or give to, any person or corporation other than
the parties hereto and the Holders any right, remedy, or claim under or by reason of this Warrant Agreement or of any covenant, condition,
stipulation, promise, or agreement hereof.

 

9.2.
Examination of the Warrant Agreement. A copy of this Warrant Agreement shall be available at all reasonable times at the office
of the Warrant Agent designated for such purpose for inspection by any Holder. Prior to such inspection, the Warrant Agent may require
any such holder to provide reasonable evidence of its interest in the Warrants.

 

9.3.
Counterparts. This Warrant Agreement may be executed in any number of original, facsimile or electronic counterparts and each
of such counterparts shall for all purposes be deemed to be an original, and all such counterparts shall together constitute but one
and the same instrument.

 

9.4.
Effect of Headings. The Section headings herein are for convenience only and are not part of this Warrant Agreement and shall
not affect the interpretation thereof.

 

10.
Certain Definitions. As used herein, the following terms shall have the following meanings:

 

(a)
“Adjustment Right” means any right granted with respect to any securities issued in connection with, or with respect
to, any issuance, sale or delivery (or deemed issuance, sale or delivery in accordance with Section 4) of Common Stock (other than rights
of the type described in Section 5.4) that could result in a decrease in the net consideration received by the Company in connection
with, or with respect to, such securities (including, without limitation, any cash settlement rights, cash adjustment or other similar
rights) but excluding anti-dilution and other similar rights.

 

    	17

     

    

  

(b)
“Exempt Issuance” means the issuance of (i) shares of Common Stock or options to employees, officers or directors
of the Company or consultants to the Company pursuant to any stock or option plan or other written agreement duly adopted for such purpose,
by a majority of the non-employee members of the Board of Directors or a majority of the members of a committee of non-employee directors
established for such purpose for services rendered to the Company, provided, however, such issuance (A) shall not exceed fifteen percent
(15%) of the Common Stock issued and outstanding as of the date hereof, (B) shall be at no less than fair market value (as measured by
the closing price of the Common Stock on the Trading Market on the date of issuance) and (C) in the first year from the date hereof shall
be issued as restricted securities; (ii) securities upon the exercise or exchange of or conversion of any securities exercisable or exchangeable
for or convertible into Common Stock issued and outstanding on the date of this Warrant Agreement, provided that such securities have
not been amended since the date of this Warrant Agreement to increase the number of such securities or to decrease the exercise price,
exchange price or conversion price of such securities (other than in connection with stock splits or combinations) or to extend the term
of such securities; (iii) securities issued pursuant to acquisitions or strategic transactions approved by a majority of the disinterested
directors of the Company or securities issued in financing transactions, the primary purpose of which is to finance acquisitions or strategic
transactions approved by a majority of the disinterested directors of the Company, provided that such securities are issued as “restricted
securities” (as defined in Rule 144) and carry no registration rights that require or permit the filing of any registration statement
in connection therewith, and provided that any such issuance shall only be to a person (or to the equity holders of a person) which is,
itself or through its subsidiaries, an operating company or an owner of an asset in a business synergistic with the business of the Company
and shall provide to the Company additional benefits in addition to the investment of funds, but shall not include a transaction in which
the Company is issuing securities primarily for the purpose of raising capital or to a person or an entity whose primary business is
investing in securities; (iv) shares of Common Stock, options or convertible securities issued to banks, equipment lessors or other financial
institutions, or to real property lessors, pursuant to a debt financing, equipment leasing or real property leasing transaction approved
by a majority of the disinterested directors of the Company but shall not include a transaction in which the company is primarily issuing
Common Stock or Common Stock Equivalents primarily for the purpose of raising capital or to a person or an entity whose primary business
is investing in securities; (v) shares of Common Stock, options or convertible securities issued in connection with the provision of
goods or services pursuant to transactions approved by a majority of the disinterested directors of the Company but shall not include
a transaction in which the company is issuing Common Stock or Common Stock Equivalents primarily for the purpose of raising capital or
to a person or an entity whose primary business is investing in securities; and (vi) shares of Common Stock, options or convertible securities
issued in connection with sponsored research, collaboration, technology license, development, investor or public relations, marketing
or other similar agreements or strategic partnerships approved by a majority of the disinterested directors of the Company but shall
not include a transaction in which the Company is primarily issuing Common Stock or Common Stock Equivalents primarily for the purpose
of raising capital or to a person or an entity whose primary business is investing in securities

 

(c)
“Trading Day” means a day on which the Common Stock is traded on a Trading Market.

 

(d)
“Trading Market” means any of the following markets or exchanges on which the Common Stock is listed or quoted for
trading on the date in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market,
the New York Stock Exchange, or OTCQB or OTCQX (or any successors to any of the foregoing).

 

(e)
“Variable Rate Transaction” means a transaction in which the Company (i) issues or sells any debt or equity securities
that are convertible into, exchangeable or exercisable for, or include the right to receive, additional shares of Common Stock either
(A) at a conversion price, exercise price or exchange rate or other price that is based upon, and/or varies with, the trading prices
of or quotations for the Common Stock at any time after the initial issuance of such debt or equity securities or (B) with a conversion,
exercise or exchange price that is subject to being reset at some future date after the initial issuance of such debt or equity security
or upon the occurrence of specified or contingent events directly or indirectly related to the business of the Company or the market
for the Common Stock or (ii) enters into, or effects a transaction under, any agreement, including, but not limited to, an equity line
of credit, whereby the Company may issue securities at a future determined price.

 

(f)
“VWAP” means, for any date, the price determined by the first of the following clauses that applies: (a) if the
Common Stock is then listed or quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date
(or the nearest preceding date) on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg
L.P. (based on a Trading Day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a
Trading Market, the volume weighted average price of the Common Stock for such date (or the nearest preceding date) on OTCQB or
OTCQX as applicable, (c) if the Common Stock is not then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common
Stock are then reported in the “Pink Sheets” published by OTC Markets Group, Inc. (or a similar organization or agency
succeeding to its functions of reporting prices), the most recent bid price per share of the Common Stock so reported, or (d) in all
other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in good faith by
the holders of a majority in interest of the Public Warrants then outstanding and reasonably acceptable to the Company, the fees and
expenses of which shall be paid by the Company

 

[Signature
Page to Follow]

 

    	18

     

    

IN
WITNESS WHEREOF, this Warrant Agent Agreement has been duly executed by the parties hereto as of the day and year first above written.

 

	 	CW PETROLEUM
    CORP
	 	 
	 	By:	              
	 	Name:	 
	 	Title:	 
	 	 	 
	 	TRANSFER
    ONLINE, INC.

	 	 
	 	By:	 
	 	Name:	 

    

	 	Title:	 

    

 

    	19

     

    

 

EXHIBIT
A

 

[UNLESS
THIS CERTIFICATE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY, A NEW YORK CORPORATION (“DTC”),
TO ISSUER OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE, OR PAYMENT, AND ANY CERTIFICATE ISSUED IS REGISTERED IN THE NAME OF CEDE
& CO. OR IN SUCH OTHER NAME AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC (AND ANY PAYMENT IS MADE TO CEDE & CO. OR
TO SUCH OTHER ENTITY AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC), ANY TRANSFER, PLEDGE, OR OTHER USE HEREOF FOR VALUE OR
OTHERWISE BY OR TO ANY PERSON IS WRONGFUL INASMUCH AS THE REGISTERED OWNER HEREOF, CEDE & CO., HAS AN INTEREST HEREIN.]

 

CW
PETROLEUM CORP

WARRANT
CERTIFICATE

NOT
EXERCISABLE AFTER [___], 2027

 

This
certifies that the person whose name and address appears below, or registered assigns, is the registered owner of the number of Public
Warrants set forth below. Each Warrant entitles its registered holder to purchase from CW Petroleum Corp, a company incorporated under
the laws of the State of Wyoming (the “Company”), at any time prior to 5:00 P.M. (Eastern Time) on [__], 2027,
one share of common stock, par value $0.0001 per share, of the Company (each, a “Public Warrant Share” and collectively,
the “Public Warrant Shares”), at an exercise price of $[___] per share, subject to possible adjustments as provided
in the Warrant Agreement (as defined below).

 

This
Warrant Certificate, with or without other Warrant Certificates, upon surrender at the designated office of the Warrant Agent, may be
exchanged for another Warrant Certificate or Warrant Certificates evidencing the same number of Public Warrants as the Warrant Certificate
or Warrant Certificates surrendered. A transfer of the Public Warrants evidenced hereby may be registered upon surrender of this Warrant
Certificate at the designated office of the Warrant Agent by the registered holder in person or by a duly authorized attorney, properly
endorsed or accompanied by proper instruments of transfer, a signature guarantee, and such other and further documentation as the Warrant
Agent may reasonably request and duly stamped as may be required by the laws of the State of New York and of the United States of America.

 

The
terms and conditions of the Public Warrants and the rights and obligations of the holder of this Warrant Certificate are set forth in
the Warrant Agent Agreement dated as of [___], 2022 (the “Warrant Agreement”) between the Company and Transfer Online,
Inc. (the “Warrant Agent”). A copy of the Warrant Agreement is available for inspection during business hours at the
office of the Warrant Agent.

 

This
Warrant Certificate shall not be valid or obligatory for any purpose until it shall have been countersigned by an authorized signatory
of the Warrant Agent.

 

WITNESS
the facsimile signature of a proper officer of the Company.

 

	 	CW PETROLEUM
    CORP
	 	 
	 	By:	            
	 	Name:	 
	 	Title:	 

    

 

    	20

     

    

 

Dated:
____________

 

Countersigned:

 

	TRANSFER
    ONLINE, INC.	 
	 	 
	By:	                	 
	Name:	 	 
	Title:	 	 

 

PLEASE
DETACH HERE

 

Certificate
No.:_________Number of Public Warrants: ______

 

WARRANT
CUSIP NO.: _________

 

    	21

     

    

 

EXHIBIT
B

 

[Form
of Election to Purchase]

 

(To
Be Executed Upon Exercise Of Warrants not evidenced by a Global Certificate)

 

TO:
CW PETROLEUM CORP 

 

(1)
The undersigned hereby elects to purchase Warrant Shares of the Company pursuant to the terms of the attached Warrant (only if exercised
in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.

 

(2)
Payment shall take the form of (check applicable box):

 

[  ]
in lawful money of the United States; or

 

[  ]
if permitted the cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection
2(c), to exercise this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure
set forth in subsection 2(c).

 

(3)
Please issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:

 

	 	 

 

The
Warrant Shares shall be delivered to the following DWAC Account Number:

 

	 	 	 
	 	 	 
	 	 	 

 

(4)
Accredited Investor. If the Warrant is being exercised via cash exercise, the undersigned is an “accredited investor”
as defined in Regulation D promulgated under the Securities Act of 1933, as amended.

 

[SIGNATURE
OF HOLDER]

Name
of Investing Entity:

Signature
of Authorized Signatory of Investing Entity:

Name
of Authorized Signatory:

Title
of Authorized Signatory:

Date:

 

    	22

     

    

 

EXHIBIT
C

 

AUTHORIZED
REPRESENTATIVES

 

	Name	 	Title	 	Signature
	Christopher Williams	 	Chief Executive Officer	 	 

 

    	23Exhibit
10.3

 

EMPLOYMENT
AGREEMENT

 

This
Employment Agreement (this “Agreement”) is made and entered into as of June 6, 2022, by and between CW Petroleum Corp,
a Wyoming corporation (the “Company”), and Christopher Williams (the “Executive”). This Agreement
will become effective immediately on the date after completion by the Company of an initial public offering (such date, the “Commencement
Date”); provided that if (a) the Company does not complete an initial public offering by December 31, 2022, or (b) the
Executive does not remain continuously employed by the Company from the date hereof through date the Company completes an initial public
offering, this Agreement shall be void ab initio (e.g., it shall never take effect).

 

RECITALS

 

WHEREAS,
the Executive was appointed as the Company’s Chief Executive Officer in April 2018;

 

WHEREAS,
the Board of Directors of the Company (the “Board”) and the Executive desire to enter into the Agreement as of the
Commencement Date pursuant to the terms hereof to assure the Company of the Executive’s continued employment in an executive capacity
and to compensate him therefor;

 

WHEREAS,
the Board considers the establishment and maintenance of a sound management to be essential to protecting and enhancing the best interests
of the Company and its stockholders; and

 

WHEREAS,
the Board has determined that appropriate steps should be taken to retain the Executive and to reinforce and encourage his continued
attention and dedication to his assigned duties and the Company desires to retain the services of the Executive, and the Executive desires
to be employed by the Company pursuant to the terms and conditions of this Agreement.

 

WHEREAS,
the Company and the Executive both acknowledge that there is no assurance that the Company will complete an initial public offering prior
to December 31, 2022 or at all at any time and that if it does not, the Commencement Date will not occur and this Agreement will not
take effect.

 

NOW,
THEREFORE, in consideration of the mutual covenants and agreements contained herein, and with reference to the above recitals, the parties
hereby agree as follows:

 

ARTICLE
1

TERM
OF EMPLOYMENT

 

1.1 Term
of Employment. The “Term” of employment shall mean the period commencing on the Commencement Date and ending on
the date the Executive’s employment terminates pursuant to Article 6.

 

ARTICLE
2

POSITION
AND DUTIES; BOARD APPOINTMENT

 

2.1 Position
and Duties. The Company shall employ the Executive as its Chief Executive Officer. The Executive shall (a) perform the duties
of Chief Executive Officer as set forth in the Company’s Bylaws, and such other duties as may be modified from time to time by
the Board provided that such duties are consistent with the Executive’s present duties and with the Executive’s position
(any modification of Executive’s duties that are required by virtue of the Company becoming publicly traded shall be deemed to
be consistent with Executive’s present duties and position); (b) be a full-time employee devoting his attention and energies
to the business of the Company; (c) use his best efforts to promote the interests of the Company; (d) perform such functions
and services as shall lawfully be directed by the Board; (e) act in accordance with the policies and directives of the Company;
and (f) report directly to the Board.

 

    	 

    	 

    

 

2.2 Restrictions.
Except as provided in Section 8.2, the Executive covenants and agrees that, while actually employed by the Company,
he shall not engage in any employment, business or activity that is in any way competitive with the business or proposed business of
the Company, whether for compensation or otherwise, without the prior consent of the Board. However, the Executive may, without the prior
consent of the Board, (a) participate in charitable, community or professional activities, provided that such activities do not
materially interfere with the services required under this Agreement, (b) make passive personal investments or conduct personal
business, financial or legal affairs or other personal matters if those activities do not materially interfere with the services required
under this Agreement, (c) continue to serve on the Board of Directors of the entities approved by the Company’s Compensation
Committee (or Board, if there is no Compensation Committee in place), only so long as each such entity does not engage in any business
or activity that is in any way competitive with the business or proposed business of the Company.

 

2.3 Board
Position. The During the Term the Executive will be considered by the Board (or designated committee thereof) for nomination to election
to the Board by the Company’s stockholders consistent with all other directors and subject to the Company’s Articles of Incorporation
and Bylaws, each as may be amended from time to time, applicable law, and rules of NASDAQ or any stock exchange on which the Company’s
shares are or become listed.

 

ARTICLE
3

COMPENSATION

 

3.1 Base
Salary. As compensation for the services to be rendered by the Executive pursuant to this Agreement, the Company hereby agrees to
pay the Executive an annual base salary (the “Base Salary”) of Three Hundred and Twenty Five Thousand Dollars (U.S.
$325,000) during the Term of this Agreement, which amount shall be reviewed by the Board (or designated committee thereof) at least annually
and may be increased (but not reduced) by the Board (or designated committee thereof) in such amounts as the Board (or designated committee
thereof) deems appropriate. The Base Salary shall be paid in accordance with the normal payroll practices of the Company.

 

3.2 Bonus.
The Executive shall be eligible to receive an annual bonus of up to fifty percent (50%) of his Base Salary based on the Company’s
and the Executive’s attaining certain business goals established by the Board (or designated committee thereof) (the “Bonus”).
Provided that the Commencement Date occurs during the first half of a calendar year, the annual goals for the calendar year in which
the Commencement Date occurs shall be determined and communicated in writing to the Executive no later than ninety (90) days after
the Commencement Date. The annual goals for each subsequent year during the Term shall be determined and communicated, in writing, to
the Executive no later than ninety (90) days after the first day of the year. In addition, the Executive may be entitled to receive
such additional bonus amounts as the Board (or designated committee thereof) shall determine in its discretion. In determining such additional
amounts, if any, the Board (or designated committee thereof) shall consider, among other things, the Executive’s contribution to
the accomplishment of the Company’s long-range business goals, the success of various corporate strategies in which the Executive
participated, and the Executive’s unique services in connection with the maintenance of or increase in stockholder value in the
Company. Any bonus shall be paid as promptly as practicable following the end of the fiscal year, but not later than the March 15th
immediately following the end of such fiscal year.

 

    	2

    	 

    

 

3.3 Stock
Options and Related Incentive Plans. During each calendar year of the Term, the Company shall grant the Executive an award consisting
of restricted stock and/or stock options (both with reference to Company common stock) with an aggregate fair market value on the date
of grant equal to Three Hundred Thousand Dollars ($300,000) (as reasonably determined by the Company) and such award shall be granted
under the Company’s equity incentive plan existing at the time of any such grant (or a newly-adopted plan if no plan has sufficient
authorized shares to accommodate the award). The Company may grant the Executive additional stock awards for shares of the Company’s
common stock in such amounts and terms (including performance-based terms) as the Board (or designated committee therefore) deems appropriate,
with the aggregate value of such grants expected not to exceed Four Hundred and Twenty Five Thousand Dollars ($425,000) for the first
year. In addition to the foregoing, the Executive shall be eligible to participate in the Company’s existing incentive programs
and any additional or successor incentive plan or plans. Any grants made to the Executive pursuant to such plans shall provide for an
expiration date consistent with the provisions of such plans; provided, however, that in no event shall any option remain
exercisable beyond its stated expiration date.

 

3.4 Withholding.
The Company shall have the right to deduct or withhold from any payments made pursuant to this Agreement any and all amounts it is required
to deduct or withhold and any and all amounts the Executive agrees it may deduct or withhold (e.g., for federal income and employee social
security taxes and all state or local income taxes now applicable or that may be enacted and become applicable during the Term).

 

ARTICLE
4

EMPLOYEE
BENEFITS; BUSINESS EXPENSES

 

4.1 Employee
Benefits.

 

(a) Benefits. The
Company agrees that the Executive shall be entitled to all ordinary and customary perquisites afforded generally to executive officers
of the Company from time to time (except to the extent employee contributions may be required under the Company’s benefit plans
as they may now or hereafter exist), but in any event shall include any qualified or nonqualified pension, profit sharing and savings
plans, any death benefit and disability benefit plans, life insurance coverages, any medical, dental, health and welfare plans or insurance
coverages and any stock purchase programs that are approved in writing by the Board, in its sole discretion.

 

(b) Vacation.
The Executive shall be entitled to the number of paid vacation days in each calendar year determined by the Board from time to time for
its senior executive officers (prorated in any calendar year during which the Executive is employed by the Company for less than the
entire calendar year in accordance with the number of days in such calendar year during which he is so employed). The Executive shall
also be entitled to all paid holidays given by the Company to its senior executive officers.

 

4.2 Business
Expenses.

 

(a) Expenses. The
Company shall pay or reimburse the Executive for all reasonable and authorized business expenses incurred by the Executive during the
Term; such payment or reimbursement shall not be unreasonably withheld so long as said business expenses have been incurred for and promote
the business of the Company and are normally and customarily incurred by employees in comparable positions at other comparable businesses
in the same or similar market. Notwithstanding the foregoing, the Company shall not pay or reimburse the Executive for the costs of any
membership fees or dues for private clubs, civic organizations, and similar organizations or entities, unless such organizations and
the fees and costs associated therewith have first been approved in writing by the Board, in its sole discretion.

 

(b) Travel
Costs. Subject to the provisions of Section 4.2, the Company shall reimburse the Executive for expenses incurred
with business-related travel. The Executive shall be reimbursed for first class travel expenses for business-related flights.

 

    	3

    	 

    

 

(c) Records.
As a condition to reimbursement under Section 4.2, the Executive shall furnish to the Company adequate records and other
documentary evidence required by federal and state statutes and regulations for the substantiation of each expenditure. The Executive
acknowledges and agrees that failure to furnish the required documentation may result in the Company denying all or part of the expense
for which reimbursement is sought.

 

(d) Time
Requirements. Executive understands that no reimbursements will be provided under this Section 4.2, unless Executive
submits a request for reimbursement in accordance with this Section 4.2 within six (6) months after incurring the
expense and that any reimbursable expense will be reimbursed not later than six (6) months after submission.

 

ARTICLE
5

CHANGE
OF CONTROL

 

5.1 Payments
Upon Change of Control.

 

(a) Change
of Control Payment. Notwithstanding Article 1, in the event of a Change of Control (as defined in Section 5.3)
of the Company during the Term while the Executive remains employed by the Company, the Company shall pay to the Executive, concurrently
with the consummation of such Change of Control, a lump sum amount, in cash, equal to two (2) times the sum of (A) the Executive’s
annual Base Salary (determined as the Executive’s latest annual Base Salary during the Term prior to the Change of Control) and
(B) the Bonus (determined as one hundred percent (100%) of the Executive’s eligible bonus during the Term prior to the
Change of Control) (the “Change of Control Payment”). The date on which the Executive becomes entitled to receive
the Change of Control Payment under this Section 5.1(a) shall be referred to herein as the “Change of
Control Payment Date.”

 

(b) Effect
of Termination of Employment.

 

(i)
If the Executive’s employment with the Company is terminated pursuant to Section 6.2 prior to the Change
of Control Payment Date, then notwithstanding anything in Section 5.1(a), the Executive shall be entitled to receive
all amounts due pursuant to Section 6.2 and he shall not be entitled to receive any payments under Section 5.1(a).

 

(ii)
If the Executive’s employment with the Company is terminated pursuant to Section 6.2 on the Change of Control
Payment Date or within ninety (90) days thereafter, then notwithstanding anything set forth in Section 6.2, the
Company shall not be required to make any payments to the Executive pursuant to Section 6.2 and the Executive shall
be entitled to receive the amounts due pursuant to Section 5.1(a). For the avoidance of doubt, the Executive shall only
be entitled to one Change of Control Payment under Section 5.1. In addition, the Company shall provide the Executive
(and his family members) with twelve (12) months of paid COBRA coverage for any Company sponsored group health plan (excluding any flexible
spending account) in which the Executive is enrolled at the time of Executive’s termination of employment (provided, however, that
if doing so would result in adverse tax consequences (e.g., under Internal Revenue Code Section 105(h)), the Company shall instead
pay executive an amount equal to one (1) month of COBRA continuation premiums with respect to each such group health plan on the first
day of each of the first twelve (12) months following Executive’s termination of employment).

 

5.2 Acceleration
of Equity Awards Upon Change of Control. If the Executive becomes entitled to the Change of Control Payment, then on the Change of
Control Payment Date, the Company shall vest all of the Executive’s unvested stock options and other equity awards (if any) outstanding
on the Change of Control Payment Date, regardless of when such options or equity awards were granted.

 

    	4

    	 

    

 

5.3 Definition
of Change of Control. For purposes of this Agreement “Change of Control” means the occurrence of any of the following:

 

(a)
the sale, lease, transfer, conveyance or other disposition (other than by way of merger or consolidation, but not including any underwritten
public offering registered under the Securities Act of 1933, as amended (“Public Offering”), or any offering of securities
under Rule 144A promulgated under the Securities Act of 1933, as amended (“Rule 144A Offering”)), in one (1) or a
series of related transactions of all or substantially all of the assets of the Company taken as a whole to any individual, corporation,
limited liability company, partnership, or other entity (each, a “Person”) or group of Persons acting together (each
a “Group”) (other than any of the Company’s wholly-owned subsidiaries or any Company employee pension or benefits
plan);

 

(b)
the consummation of any transactions (including any stock or asset purchase, sale, acquisition, disposition, merger, consolidation or
reorganization, but not including any Public Offering or Rule 144A Offering) the result of which is that any Person or Group (other than
any of the Company’s wholly-owned Subsidiaries, any underwriter temporarily holding securities pursuant to a Public Offering or
any Company employee pension or benefits plan), becomes the beneficial owners of more than forty percent (40%) of the aggregate
voting power of all classes of stock of the Company having the right to elect directors under ordinary circumstances.

 

ARTICLE
6

TERMINATION
OF EMPLOYMENT

 

6.1 Termination
by the Company for Cause.

 

(a)
The Company may, during the Term, upon written notice to the Executive, terminate the Executive’s employment under this Agreement
and discharge the Executive for Cause (as defined in Section 6.1(b)) and, in such event, except as set forth in Section 6.1,
neither party shall have any rights or obligations under Article 1, Article 2, Section 3.1, Section 3.2,
or Article 4; provided, however, that the Company shall pay the Executive any amount due and owing as of
the Termination Date pursuant to Section 3.1 and Section 3.2 (excluding a Bonus for the year
in which the termination occurs) and Article 4.

 

(b)
As used herein, the term “Cause” shall refer to the termination of the Executive’s employment as a result of
any one or more of the following: (i) any conviction of, or pleading of nolo contendre by, the Executive for any felony; (ii) any
willful misconduct of the Executive which has a materially injurious effect on the business or reputation of the Company; (iii) the
dishonesty of the Executive which has a materially injurious effect on the business or reputation of the Company; or (iv) a material
failure to consistently discharge his duties under this Agreement other than such failure resulting from his Disability (as defined in Section 6.3(b)).
For purposes of Section 6.1, no act or failure to act, on the part of the Executive, shall be considered “willful”
if it is done, or omitted to be done, by the Executive in good faith or with reasonable belief that his action or omission was in the
best interest of the Company. The Executive shall have the opportunity to cure any such acts or omissions under clause (iv) above
within thirty (30) days of the Executive’s receipt of a copy of a resolution, duly adopted by the affirmative vote of not
less than three-quarters of the entire membership of the Board at a meeting of the Board called and held for the purpose (after reasonable
notice to the Executive and an opportunity for him, together with his counsel, to be heard before the Board), finding that in the good
faith opinion of the Board the Executive was guilty of acts or omissions constituting “Cause” and specifying the particulars
thereof in detail.

 

    	5

    	 

    

 

6.2 Termination
by the Company Without Cause or by the Executive for Good Reason.

 

(a)
The Board acting for the Company shall have the right, at any time in its sole discretion, to terminate the Executive’s employment
under this Agreement at any time for any reason other than Cause, or no reason at all (any such termination, a termination “Without
Cause”), upon not less than thirty (30) days prior written notice to the Executive, and the Executive may, by written
notice to the Board, terminate his employment under this Agreement (and he hereby has such right) by reason of any act, decision or omission
by the Company or the Board that: (i) materially diminishes the Executive’s Base Salary; (ii) materially diminishes the
Executive’s authority, duties, or responsibilities (other than such changes that typically occur in connection with a company becoming
a publicly-traded company); (iii) relocates the Executive without his consent from the Company’s offices located at 2717 Commercial
Center Blvd., Suite E200 PMB 264, Katy, Texas 77494 to any other location in excess of fifty (50) miles beyond the geographic limits
of Katy, Texas that increases the Executive’s one-way commute to work by at least fifty (50) miles based on the Executive’s
primary residence immediately prior to the time such relocation is announced; or (iv) constitutes a material breach of this Agreement
(each a “Good Reason”). The Executive must give the Company written notice of the condition that gives rise to the
Good Reason within ninety (90) days of the occurrence of the condition, in which event the Company shall have thirty (30) days
to remedy the condition, and after which the Executive may resign for Good Reason within ninety (90) days after the Company fails
to reasonably remedy the condition.

 

(b)
In the event the Company or the Executive shall exercise the termination right granted pursuant to Section 6.2(a), then
except as set forth below, neither party shall have any rights or obligations under Article 1, Article 2, Section 3.1, Section 3.2,
or Article 4; provided, however, that the Company shall pay to the Executive (i) an amount equal to
twenty four (24) months of the Executive’s Base Salary (determined as the Executive’s last annual Base Salary during the
Term prior to such termination) plus two times the Bonus (determined as one hundred percent (100%) of the Executive’s eligible
bonus during the Term prior to such termination), and (ii) any amount due and owing as of the Termination Date pursuant to Section 3.1, Section 3.2 (including
a Bonus for the year in which the termination occurs prorated to the date of termination based on the Executive’s average bonus
received for the immediately preceding three (3) years) and Article 4. Such amounts shall be paid in a single lump sum seventy
five (75) days after Executive terminates employment, provided, however, that the payments pursuant to clause (i) above are contingent
on the Executive having executed a release in favor of the Company within sixty (60) days following Executive’s termination of
employment and not thereafter revoking such release. In addition, the Company shall provide the Executive (and his family members) with
twelve (12) months of paid COBRA coverage for any Company sponsored group health plan (excluding any flexible spending account) in which
the Executive is enrolled at the time of Executive’s termination of employment (provided, however, that if doing so would result
in adverse tax consequences (e.g., under Internal Revenue Code Section 105(h)), the Company shall instead pay executive an amount
equal to one (1) month of COBRA continuation premiums with respect to each such group health plan on the first day of each of the first
twelve (12) months following Executive’s termination of employment).

 

6.3 Termination
of Employment Upon Death Or Disability.

 

(a) Death. The
Executive’s employment hereunder shall terminate automatically upon his death during the Term. Upon such termination, the Company
neither party shall have any rights or obligations under Article 1, Article 2, Section 3.1, Section 3.2,
or Article 4; provided, however, that the Company shall pay the Executive’s estate any amount due
and owing as of the Termination Date pursuant to Section 3.1 and Section 3.2 (excluding a
Bonus for the year in which the termination occurs) and Article 4 and the Company shall pay to such person as the
Executive shall have designated in a notice filed with the Company, or, if no such person shall be designated, to his estate as a death
benefit, a lump sum amount, in cash, equal to the Executive’s Base Salary at the rate in effect on the date of the Executive’s
death. This amount shall be exclusive of and in addition to any payments the Executive’s surviving spouse, beneficiaries or estate
may be entitled to receive pursuant to any pension or employee benefit plan or life insurance policy maintained by the Company. Any equity
awards held by the Executive shall be governed by the terms and conditions of the relevant plan and grant documents.

 

    	6

    	 

    

 

(b) Disability. If
the Company determines in good faith that the Disability of the Executive has occurred during the Term, subject to applicable laws, it
may give written notice to the Executive of its intention to terminate his employment. In such event, the Executive’s employment
with the Company shall terminate effective on the 30th day after receipt of such notice by the Executive, provided that, within the thirty (30)
days after such receipt, the Executive shall not have returned to full-time performance of his duties. During any period that the Executive
fails to perform his duties hereunder as a result of the Disability, the Executive shall continue to receive his full Base Salary and
incentive compensation until the Executive’s employment is terminated pursuant to this Section 6.3(b). Upon any
such termination neither party shall have any rights or obligations under Article 1, Article 2, Section 3.1, Section 3.2,
or Article 4; provided, however, that the Company shall pay the Executive any amount due and owing as of
the Termination Date pursuant to Section 3.1 and Section 3.2 (excluding a Bonus for the year
in which the termination occurs) and Article 4 and, after termination an amount equal to twelve (12) months of
the Executive’s Base Salary (determined as the Executive’s last annual Base Salary during the Term prior to such termination).
Such twelve (12) months of Base Salary shall be paid in a single lump sum seventy five (75) days after Executive terminates employment,
provided, however, that this payment is contingent on the Executive having executed a release in favor of the Company within sixty (60)
days following Executive’s termination of employment and not thereafter revoking such release. For purposes of this Agreement,
“Disability” shall mean the inability of the Executive to perform his duties to the Company on account of physical
or mental illness or incapacity for a period of one hundred and twenty (120) consecutive calendar days, or for a period of one hundred
and eighty (180) calendar days, whether or not consecutive, during any three hundred and sixty five (365) day period. Any equity awards
held by the Executive shall be governed by the terms and conditions of the relevant plan and grant documents.

 

6.4 Termination
by the Executive Without Good Reason. Anything in this Agreement to the contrary notwithstanding, during the Term the Executive shall
have the right, in his sole discretion, to terminate his employment under this Agreement without Good Reason upon not less than thirty
(30) days prior written notice to the Company and, in such event, neither party shall have any rights or obligations under Article
1, Article 2, Section 3.1, Section 3.2, or Article 4; provided,
however, that the Company shall pay the Executive any amount due and owing as of the Termination Date pursuant to Section 3.1 and Section 3.2 (excluding
a Bonus for the year in which the termination occurs) and Article 4. Any equity awards held by the Executive shall be
governed by the terms and conditions of the relevant plan and grant documents.

 

6.5 Acceleration
of Equity Awards. If the Company shall terminate the Executive’s employment other than pursuant to Sections 6.1 or
if the Executive shall terminate his employment for Good Reason pursuant to Section 6.2, then, in addition to any payment
the Executive is entitled to under Article 6, the Company shall vest, effective as of immediately prior to the applicable
Termination Date, all of the Executive’s unvested stock options and other equity awards (if any) outstanding as of immediately
prior to the applicable Termination Date, regardless of when such options of equity awards were granted.

 

6.6 Date
of Termination. For purposes of this Agreement “Termination Date” shall mean the date the Executive’s employment
terminates.

 

    	7

    	 

    

 

ARTICLE
7

COOPERATION

 

7.1 Certain
Events. In the event that Executive receives payment pursuant to this Agreement and the Company (or its successor) is later required
to restate its financial statements due in whole or in part to the fraud or misconduct of Executive, then Executive shall promptly repay
to the Company (or its successor) any such amounts Executive received that were based in whole or part on the financial statements that
were required to be restated and Executive shall not be entitled to any further payments that are based in whole or part on the financial
statements that were required to be restated. In addition, Executive’s bonuses and other incentive-based compensation and profits
on stock sales shall be subject to potential disgorgement pursuant to Section 304 of the Sarbanes-Oxley Act of 2002.

 

ARTICLE
8

RESTRICTIVE
COVENANTS

 

8.1 Confidential
Information. The Executive has entered into and agrees to be bound by the terms and conditions of the Company’s Confidentiality
Agreement, dated June 6, 2022 (the “Confidentiality Agreement”). The Executive agrees to execute such other documents
(including, but not limited to, new versions of the Confidentiality Agreement) as may be necessary in order to protect the Company’s
confidential and proprietary information. Expiration of this Agreement shall not have any effect on the Confidentiality Agreement, which
shall at all times remain separately and independently enforceable, subject to the terms of this Article 8.

 

8.2 Covenant
Not to Solicit. During the Term and through the one (1) year anniversary of the Termination Date, the Executive will not,
directly or indirectly, without the express written consent of the Board, solicit (a) clients, customers or accounts of the Company
for, on behalf of or otherwise related to any Competitive Business; (b) or hire any person who is or shall be in the employ or service
of the Company to leave such employ or service for employment with or service to the Executive, an affiliate of the Executive or any
third party; or (c) or hire any person who was within six (6) months of such solicitation in the employ or service of the Company
to become employed by or provide services to the Executive, an affiliate of the Executive or any third party.

 

8.3 Specific
Performance. Recognizing that irreparable damage will result to the Company in the event of the breach or threatened breach of any
of the foregoing covenants and assurances by the Executive contained in Sections 8.1 and 8.2, and that the
Company’s remedies at law for any such breach or threatened breach may be inadequate, the Company and its successors and assigns,
in addition to such other remedies which may be available to them, shall, upon making a sufficient showing under applicable law, be entitled
to an injunction to be issued by any court of competent jurisdiction ordering compliance with this Agreement or enjoining and restraining
the Executive, and each and every person, firm or company acting in concert or participation with him, from the continuation of such
breach. The obligations of the Executive and rights of the Company pursuant to this Article 8 shall survive the
termination of the Executive’s employment under this Agreement. The covenants and obligations of the Executive set forth in this Article 8 are
in addition to and not in lieu of or exclusive of any other obligations and duties the Executive owes to the Company, whether expressed
or implied in fact or law. The Company shall pay and be solely responsible for any attorney’s fees, expenses, costs and court or
arbitration costs incurred by the Executive in any matter or dispute between the Executive and the Company which pertains to this Article 8 if
the Executive prevails in the contest in whole or in part.

 

ARTICLE
9

GENERAL
PROVISIONS

 

9.1 Final
Agreement. This Agreement is intended to be the final, complete and exclusive agreement between the parties relating to the employment
of the Executive by the Company and, effective as of the Commencement Date, supersedes all prior or contemporaneous understandings, employment
agreements, representations and statements, both oral or written, relating to the subject matter hereof. No modification, waiver, amendment,
discharge or change of this Agreement shall be valid unless the same is in writing and signed by the party against which the enforcement
thereof is or may be sought.

 

    	8

    	 

    

 

9.2 No
Waiver. No waiver, by conduct or otherwise, by any party of any term, provision, or condition of this Agreement, shall be deemed
or construed as a further or continuing waiver of any such term, provision, or condition nor as a waiver of a similar or dissimilar condition
or provision at the same time or at any prior or subsequent time.

 

9.3 Rights
Cumulative. The rights under this Agreement, or by law or equity, shall be cumulative and may be exercised at any time and from time
to time. No failure by any party to exercise, and no delay in exercising, any rights shall be construed or deemed to be a waiver thereof,
nor shall any single or partial exercise by any party preclude any other or future exercise thereof or the exercise of any other right.

 

9.4 Notice.
Except as otherwise provided in this Agreement, any notice, approval, consent, waiver or other communication required or permitted to
be given or to be served upon any person in connection with this Agreement shall be in writing. Such notice shall be personally served,
sent by fax or cable, or sent prepaid by either registered or certified mail with return receipt requested or national overnight delivery
service and shall be deemed given (i) if personally served or by national overnight delivery service, when delivered to the person
to whom such notice is addressed, (ii) if given by fax or cable, when sent, or (iii) if given by mail, two (2) business
days following deposit in the United States mail. Any notice given by fax or cable shall be confirmed in writing, by overnight mail or
national overnight delivery service within forty-eight (48) hours after being sent. Such notices shall be addressed to the party
to whom such notice is to be given at the party’s address set forth below or as such party shall otherwise direct.

 

If
to the Company:

 

CW
Petroleum Corp

2717
Commercial Center Blvd.

Suite
E200 PMB 264

Katy,
Texas 77494

Attn:
Board of Directors

 

If
to the Executive:

 

Christopher
Williams

2717
Commercial Center Blvd.

Suite
E200 PMB 264

Katy,
TX 77494

 

9.5 Assignments.
This Agreement is binding upon the parties hereto and their respective successors, assigns, heirs and personal representatives. Except
as otherwise provided herein, neither of the parties hereto may make any assignment of this Agreement, or any interest herein, without
the prior written consent of the other party, except that, without such consent, this Agreement shall be assigned to any corporation
or entity which shall succeed to the business presently being operated by Company, by operation of law or otherwise, including by dissolution,
merger, consolidation, transfer of assets, or otherwise.

 

9.6 Governing
Law. This Agreement shall be construed and enforced in accordance with the laws of the State of Texas, without giving effect to the
principles of conflict of laws thereof.

 

9.7 Counterparts.
This Agreement may be executed in any number of counterparts, each of which shall be deemed an original, but all of which shall constitute
one instrument. The parties agree that facsimile copies of signatures shall be deemed originals for all purposes hereof and that a party
may produce such copies, without the need to produce original signatures, to prove the existence of this Agreement in any proceeding
brought hereunder.

 

    	9

    	 

    

 

9.8 Severability.
The provisions of this Agreement are agreed to be severable, and if any provision, or application thereof, is held invalid or unenforceable,
then such holding shall not affect any other provision or application.

 

9.9 Construction.
As used herein, and as the circumstances require, the plural term shall include the singular, the singular shall include the plural,
the neuter term shall include the masculine and feminine genders, and the feminine term shall include the neuter and the masculine genders.

 

9.10 Arbitration.
Except as otherwise provided in Section 8.4 hereof, any controversy or claim arising out of, or related to, this
Agreement, or the breach thereof, shall be settled by binding arbitration in Houston, Texas, in accordance with the employment arbitration
rules then in effect of the American Arbitration Association including the right to discovery, and the arbitrator’s decision shall
be binding and final, and judgment upon the award rendered may be entered in any court having jurisdiction thereof. Each party hereto
shall pay its or their own expenses incident to the negotiation, preparation and resolution of any controversy or claim arising out of,
or related to, this Agreement, or the breach thereof; provided, however, the Company shall pay and be solely responsible
for any attorneys’ fees and expenses and court or arbitration costs incurred by the Executive as a result of a claim brought by
either the Executive or the Company alleging that the other party breached or otherwise failed to perform this Agreement or any provision
hereof to be performed by the other party if the Executive prevails in the contest in whole or in part.

 

9.11 Code
Section 409A Compliance. Each payment under this Agreement shall be considered a separate payment for purposes of Section 409A.
A termination of employment shall not be deemed to have occurred for purposes of any provision of this Agreement providing for the payment
of any amount or benefit upon or following a termination of employment unless such termination is also a “separation from service”
within the meaning of Internal Revenue Code Section 409A (“Section 409A”) and, for purposes of this Agreement,
references to a “termination,” “termination of employment” or like terms shall mean “separation from service.”
Notwithstanding anything to the contrary in this Agreement, if the Executive is a “specified employee” (within the meaning
of Section 409A) on the date of the Executive’s separation from service, then any payments or benefits that otherwise would
be payable under this Agreement within the first six months following the Executive’s separation from service (the “409A
Suspension Period”), shall instead be paid in a lump sum within fourteen (14) days after the end of the sixth month period
following the Executive’s separation from service, or Executive’s death, if sooner, but only to the extent that such payments
or benefits provide for the “deferral of compensation” within the meaning of Section 409A, after application of the
exemptions provided in Sections 1.409A-1(b)(4) and 1.409A-1(b)(9)(ii)-(v) thereof. After the 409A Suspension Period, the Executive
will receive any remaining payments and benefits due pursuant to this Agreement in accordance with its terms (as if there had not been
any suspension beforehand). To the extent that severance payments or benefits under this Agreement are conditioned on the execution of
a release by Executive, Executive shall forfeit all rights to such payments and benefits unless such release is signed and delivered
to the Company within the time required by this Agreement. Whenever a payment under this Agreement specified a payment period with respect
to a number of days, the actual date of payment within the specified period shall be within the sole discretion of the Company. The Company
will cooperate with the Executive in making any amendments to this Agreement that the Executive reasonably requests to avoid the imposition
of taxes or penalties under Section 409A of the Code provided that such changes do not provide the Executive with additional benefits
(other than de minimus benefits) under this Agreement.

 

9.12 Survival.
The covenants contained in Articles 5, 6, 9.1 – 9.5 and 9.10 – 9.13 shall
survive any termination of the Executive’s employment with the Company and any expiration or termination of this Agreement.

 

9.13 No
Mitigation or Offset. The Executive shall not have any duty to seek other employment or to reduce any amounts or benefits payable
to him under Section 1.1 or Article 6, and no such amounts or benefits shall be reduced, on account
of any compensation received by the Executive from any other employment or source. The Company shall not have the right to offset any
amount owed to it against payments due to the Executive under Section 1.1, Article 5 or Article
6 (other than as expressly provided therein).

 

[SIGNATURE
PAGE FOLLOWS]

 

    	10

    	 

    

 

IN
WITNESS WHEREOF, the parties have executed this Agreement as of the date first above written.

 

	 	CW
    PETROLEUM CORP
	 	 

    
	 
	 	By:	/s/
                                            Greg Roda

	 	Name: 	Greg
    Roda
	 	Title:	Director
	 	 
	 	EXECUTIVE
	 	 	 
	 	 	/s/
                                            Christopher Williams

	 	 	Christopher
    Williams, an Individual

 

    	11

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00347-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00347-of-00352.parquet"}]]